Coupling Krebs cycle metabolites to signalling in immunity and cancer
Open accessAbstract
Metabolic reprogramming has become a key focus for both immunologists and cancer biologists, with exciting advances providing new insights into the mechanisms underlying disease. There is now extensive evidence that intermediates and derivatives of the mitochondrial Krebs cycle—metabolites traditionally associated with bioenergetics or biosynthesis—also possess ‘non-metabolic’ signalling functions. In this review, we summarize the non-metabolic signalling mechanisms of succinate, fumarate, itaconate, 2-hydroxyglutarate isomers (d-2-hydroxyglutarate and l-2-hydroxyglutarate) and acetyl-CoA, with a specific focus on how such signalling pathways alter immune cell and transformed cell function. We believe that the insights gained from immune and cancer cells that are summarized here will also be useful for understanding and treating a range of other diseases. Intermediate metabolites of the Krebs cycle serve bioenergetic and biosynthetic needs but have recently also been linked to signalling. The authors of this Review summarize such non-metabolic signalling functions of succinate, fumarate, itaconate, 2-hydroxyglutarate isomers and acetyl-CoA in both immune cells and cancer cells.
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that Krebs cycle intermediates—succinate, itaconate, fumarate, 2-HG, and acetyl-CoA—act as signalling molecules in immune cells and cancer beyond bioenergetics. It synthesizes mechanisms by which these metabolites alter inflammation, epigenetics, and tumorigenesis, and discusses therapeutic implications.
Key findings
- Succinate accumulates in LPS/IFN-γ-treated macrophages and promotes inflammation via SUCNR1, HIF-1α stabilization, mtROS/RET at complex I, succinylation, and epigenetic regulation; SDH inhibition by DMM/malonate reduces LPS-induced HIF-1α, IL-1β, and ROS and boosts IL-10/IL-1RA.
- Itaconate, produced by IRG1/CAD from cis-aconitate, is anti-inflammatory: it inhibits SDH, induces Nrf2 via KEAP1 cysteine alkylation (e.g., C151), and can regulate the IκBζ–ATF3 axis; 4-OI was protective in LPS lethality. In peritoneal tumours, tumour-infiltrating macrophage-derived itaconate boosted OXPHOS/mtROS/MAPK and tumour growth.
- Fumarate acts as an oncometabolite and immunomodulator: FH mutations cause HLRCC; fumarate succinates KEAP1, GAPDH, ACO2, and Fe-S proteins, inhibits α-KGDDs/TETs/JMJDs, drives pseudohypoxia and EMT; in β-glucan-trained monocytes fumarate accumulation is required for trained immunity and H3K4me3 at Tnf/Il6.
- 2-HG enantiomers regulate immunity/cancer: D-2-HG from mutant IDH1/2 inhibits α-KGDDs (KDM IC50 24–106 μM; FIH 1.5 mM; PHD2 7.3 mM) and accumulates up to 35 mM in IDH-mutant glioma; L-2-HG rises up to 1.5 mM in TCR-triggered mouse CD8+ T cells and enhances anti-tumour capacity. Acetyl-CoA from citrate via ACLY supports histone acetylation and immune/tumour gene expression.
Methods
- Narrative review; no primary experimental design, sample, or dataset is reported.
- Synthesizes published literature on succinate, itaconate, fumarate, 2-HG, and acetyl-CoA in immunity and cancer; no systematic search strategy, inclusion criteria, or meta-analysis is described.
- Main analysis is conceptual/mechanistic synthesis with figures and therapeutic discussion.
Limitations
- Stated: limited human and in vivo data; rapid steady-state metabolism makes accurate in vivo snapshots challenging; human immune cell studies are limited.
- Stated: many open questions remain about metabolite ratios/compartments, unidentified GPCRs/transporters, and whether metabolites are biomarkers or drivers; oncometabolite findings often come from rare cancer syndromes.
- Evident: as a narrative review, it does not systematically assess evidence quality or quantify bias; many mechanistic claims rely on mouse/cell-line studies and cited primary papers.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 300 cited sources checked · 0 supported · 0 flagged
- Premisecitation
A selective SUCNR1 antagonist is protective in hypertension, a disease in which succinate is elevated.
“A selective antagonist for human and rat has been shown to be protective in hypertension, a disease in which succinate is elevated11.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Hollander, A. P., Corke, K. P., Freemont, A. J. & Lewis, C. E. Expression of hypoxia-inducible factor 1α by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 44, 1540–1544 (2001). source
Not checked in the free run.
- Premisereasoning
LPS can stabilize HIF-1α indirectly by increasing succinate levels.
“LPS can also stabilize HIF-1α indirectly, by increasing succinate levels.”
Quote in the paperSubstantial claim - Premisecitation
HIF-1 transcriptionally directs a switch in metabolism from oxidative phosphorylation to glycolysis, allowing rapid ATP production without oxygen.
“It transcriptionally directs a switch in metabolism from oxidative phosphorylation to glycolysis, which allows rapid ATP production without the need for oxygen15.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Lewis, G. D. et al. Metabolic signatures of exercise in human plasma. Sci. Transl. Med. 2, 33ra37 (2010). source
Not checked in the free run.
- Premisenone given
HIF-1α is regulated by prolyl hydroxylases, α-KG-dependent dioxygenases that convert α-KG to succinate and use molecular oxygen to hydroxylate HIF-1α.
“HIF-1α is tightly regulated by prolyl hydroxylases (PHD), a class of α-ketoglutarate (α-KG)-dependent dioxygenases (α-KGDDs) that convert α-KG to succinate and use molecular oxygen to hydroxylate HIF-1α.”
Quote in the paperSubstantial claim - Premisecitation
Priming of DCs with succinate and antigen simultaneously elevates antigen-specific T cell activation, increasing TNFα and IFN-γ production.
“Priming of DCs with succinate and antigen simultaneously, elevates antigen-specific T cell activation, increasing TNFα and IFN-γproduction from these cells4.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
Not checked in the free run.
- Premisecitation
Succinate accumulation in tumours promotes angiogenesis via upregulation of VEGF in a HIF-1α-independent manner.
“More recently, however, it has been demonstrated that succinate accumulation in tumours promotes angiogenesis via upregulation of vascular endothelial growth factor (VEGF) in a HIF-1α-independent manner.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999). source
Not checked in the free run.
- Premisecitation
SUCNR1 ligation on MoDC or the U937 macrophage cell line induces cell migration.
“SUCNR1 ligation on MoDC or the U937 macrophage cell line induces cell migration, suggesting that succinate can act as a chemokine4.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
Not checked in the free run.
- Premisecitation
Tissue and circulating succinate is elevated in chronic inflammatory settings such as models of diet-induced obesity.
“Tissue and circulating succinate is also elevated in other chronic inflammatory settings such as models of diet-induced obesity8.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Schneider, C. et al. A metabolite-triggered tuft cell–ILC2 circuit drives small intestinal remodeling. Cell 174, 271–284.e14 (2018). source
Not checked in the free run.
- Premisecitation
Brown adipocytes sequester extracellular succinate, which increases UCP1 activity as a consequence of elevated mtROS.
“It was demonstrated that brown adipocytes possess a unique capacity to sequester extracellular succinate, which serves to increase UCP1 activity as a consequence of elevated mtROS160.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Chesnelong, C. et al. Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro-Oncol. 16, 686–695 (2014). source
Not checked in the free run.
- Premisecitation
Succinate activates ERK1/2 and STAT3 in a SUCNR1-dependent manner.
“Succinate instead activates extracellular regulated kinase (ERK) 1/2 and signal transducer and activator of transcription 3 (STAT3) in a SUCNR1-dependent manner23.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999). source
Not checked in the free run.
- Premisecitation
Succinate is increased in synovial fluids from rheumatoid arthritis patients.
“This correlates with an observed increase in succinate in synovial fluids from rheumatoid arthritis (RA) patients suggesting that chronically elevated succinate is pathological in this setting6.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Lei, W. et al. Activation of intestinal tuft cell-expressed Sucnr1 triggers type 2 immunity in the mouse small intestine. Proc. Natl Acad. Sci. USA. 115, 5552–5557 (2018). source
Not checked in the free run.
- Premisecitation
Ligation of TLR4 by LPS can transcriptionally induce HIF-1α and a range of HIF-1α target genes under hypoxic and normoxic conditions in an NF-κB-dependent manner.
“Ligation of TLR4 by LPS can transcriptionally induce HIF-1α and the induction of a range of HIF-1α target genes under hypoxic and also normoxic conditions2, in an NF-κB-dependent manner19.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
Not checked in the free run.
- cites [19] Tannahill, G. M. & O’Neill, L. A. The emerging role of metabolic regulation in the functioning of Toll-like receptors and the NOD-like receptor Nlrp3. FEBS Lett. 585, 1568–1572 (2011). source
Not checked in the free run.
- Premisecitation
Macrophage activation and IL-1β production are decreased in the absence of SUCNR1 following LPS treatment and in a model of antigen-induced arthritis.
“Macrophage activation and IL-1β production are decreased in the absence of SUCR1 both following LPS treatment and in a model of antigen-induced arthritis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261–1269 (2008). source
Not checked in the free run.
- Premisecitation
HIF-1α expression is increased in synovial joints of rheumatoid arthritis patients.
“Intriguingly, HIF-1α expression is also increased in synovial joints of RA patients7 suggesting that succinate may act in two ways to increase inflammation in RA: via SUCNR1 and HIF-1α.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Nadjsombati, M. S. et al. Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit. Immunity 49, 33–41.e7 (2018). source
Not checked in the free run.
- Premisereasoning
HIF-1α is vital for the switch to glycolysis observed in M1 macrophages and DCs following stimulation.
“HIF-1α is vital for the switch to glycolysis observed in M1 macrophages and DCs following stimulation.”
Quote in the paperSubstantial claim - Premisecitation
Succinate acts in an autocrine and paracrine manner to increase IL-1β production in macrophages.
“Littlewood-Evans and colleagues (2016) have demonstrated that succinate can act in an autocrine and paracrine manner to increase IL-1β production in macrophages5.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261–1269 (2008). source
Not checked in the free run.
- Interpretationreasoning
Following ischemia/hypoxia or SDH mutations, elevated succinate can potentiate the hypoxic phenotype by further HIF-1α stabilization.
“As such, following ischemia/hypoxia, or when SDH operation is affected by genetic aberrations (such a tumors harboring SDH mutations) elevated succinate can potentiate the hypoxic phenotype by leading to further HIF-1α stabilization.”
Quote in the paperSubstantial claim - Premisecitation
DI significantly and acutely depletes GSH levels.
“DI was shown to significantly and acutely deplete GSH levels, confirming it was indeed an activated Michael acceptor59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
In DI-treated BMDMs, genes involved in Phase II conjugation, glutathione conjugation and biological oxidations are upregulated.
“Lampropoulou and colleagues (2016) reported an upregulation of genes involved in Phase II conjugation, glutathione conjugation and biological oxidations from an RNA-seq screen performed in DI-treated BMDMs50.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
Not checked in the free run.
- Premisecitation
BMDMs activated by LPS and pre-treated with dimethyl itaconate exhibit potent inhibition of pro-inflammatory mediators including NO, ROS and cytokines IL-6, IL-12p70 and IL-1β.
“Importantly, Lampropoulou and colleagues (2016) first demonstrated that bone-marrow derived macrophages (BMDMs) activated by LPS and pre-treated with a cell permeable methyl ester derivative of itaconate, dimethyl itaconate (DI), exhibited potent inhibition of pro-inflammatory mediators including nitic oxide (NO), ROS and the cytokines IL-6, IL-12p70 and IL-1β13,50.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
Not checked in the free run.
- cites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
Not checked in the free run.
- Premisenone given
ROS production in this setting is believed to result from reverse electron transport at complex I of the electron transport chain.
“ROS production in this setting is believed to be as a result of reverse electron transport (RET) at complex I of the electron transport chain.”
Quote in the paperSubstantial claim - Interpretationreasoning
Succinate and α-KG can remodel the epigenome.
“In this way succinate, and α-KG, can remodel the epigenome.”
Quote in the paperSubstantial claim - Premisecitation
Treatment of mouse fibroblasts with the SDH inhibitor 3-nitropropionic acid increases succinylation.
“Treatment of mouse fibroblasts with the SDH inhibitor 3-nitropropionic acid increases succinylation38.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] Jin, Z., Wei, W., Yang, M., Du, Y. & Wan, Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell. Metab. 20, 483–498 (2014). source
Not checked in the free run.
- Premisecitation
Succinate elevation in response to LPS potentiates inflammatory signalling, particularly IL-1β, in a HIF-1α-dependent manner.
“A critical consequence of succinate elevation in response to LPS is the potentiation of inflammatory signalling and in particular IL-1β, in a HIF-1α-dependent manner2.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
Not checked in the free run.
- Premisecitation
A hypoxia response element exists in the IL-1β promoter.
“The finding that hypoxia was capable of inducing IL-1β production in astrocytes in an NF-κB-independent, HIF-1α-dependent, mechanism 28 led to the discovery of a HRE in the IL-1β promoter 2.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
Not checked in the free run.
- cites [28] Rasola, A., Neckers, L. & Picard, D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 24, 455–463 (2014). source
Not checked in the free run.
- Premisecitation
Itaconate and 4-OI have similar thiol reactivity profiles.
“itaconate and 4-OI were shown to have a similar thiol reactivity profile”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
Innate immune training involves epigenetic modifications leading to stronger gene transcription upon re-stimulation.
“At a molecular level this involves epigenetic modifications, leading to stronger gene transcription upon re-stimulation, as opposed to gene recombination that occurs in the adaptive memory response.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Peyssonnaux, C. et al. Cutting edge: essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J. Immunol. 178, 7516–7519 (2007). source
Not checked in the free run.
- Premisecitation
HIF-1α is required for the training effect induced by β-glucan.
“Inhibition of HIF-1α with ascorbate impaired the training effect induced by β-glucan and decreased TNF-α production in these cells, demonstrating a requirement for HIF-1α in the training effect induced by β-glucan.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] El-Khoury, R. et al. Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br. J. Pharmacol. 171, 2243–2249 (2014). source
Not checked in the free run.
- Premisecitation
Hypoxia and ischemia, as well as decreased oxidative phosphorylation, drive succinate accumulation in the mitochondrial matrix.
“It should be noted that hypoxia and ischemia, as well as decreased oxidative phosphorylation, drive succinate accumulation in the mitochondrial matrix26,27.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [26] Wu, W. & Zhao, S. Metabolic changes in cancer: beyond the Warburg effect. Acta Biochim. Biophys. Sin. (Shanghai) 45, 18–26 (2013). source
Not checked in the free run.
- cites [27] Selak, M. A. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell. 7, 77–85 (2005). source
Not checked in the free run.
- Premisecitation
α-KG and succinate regulate the activity of JMJD histone demethylases and TET family 5mC hydroxylases.
“α-KG and succinate can regulate the activity of other members of the α-KGDD family of enzymes, in particular those involved in the regulation of histone and DNA demethylation, the α-KG-dependent Jumonji C-domain containing histone demethylases (JMJDs) and the Ten eleven translocation (TET) family of 5mC hydroxylases, which play a role in DNA demethylation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431–435 (2014). source
Not checked in the free run.
- Premisecitation
Compared with malonate, itaconate is a relatively weak competitive inhibitor of SDH.
“However, it must also be noted that, compared with malonate, itaconate is a relatively weak competitive inhibitor of SDH47,49, which raised the question as to whether any additional mechanisms could contribute to the anti-inflammatory effects of itaconate.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [47] Xie, L. et al. First succinyl-proteome profiling of extensively drug-resistant Mycobacterium tuberculosis revealed involvement of succinylation in cellular physiology. J. Proteome Res. 14, 107–119 (2015). source
Not checked in the free run.
- cites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
Not checked in the free run.
- Premisecitation
The increase in pro-inflammatory cytokines in Mtb-infected Irg1-deficient mice is independent of IRG1's anti-bactericidal activity.
“this effect was independent of its ability to act as an anti-bactericidal agent73.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] Brennan, M. S. et al. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One 10, e0120254 (2015). source
Not checked in the free run.
- Premisecitation
Levels of 2,3-dicarboxypropyl cysteine (itaconate-cysteine adduct) are significantly increased in LPS-activated BMDMs.
“Further supporting the hypothesis that itaconate was a thiol reactive metabolite, a significant increase in the levels of the metabolite 2,3-dicarboxypropyl cysteine (itaconate-cysteine adduct), akin to (S)-2-succinocysteine (2SC) a breakdown product of fumarate-mediated protein succination, was observed in LPS-activated BMDMs59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
IRG1 mediates the immunomodulatory effects of CORM2-induced HMOX1 on TNF-α production in LPS-activated macrophages and in a murine endotoxin shock model.
“IRG1 has also been shown to mediate the immunomodulatory effects of CO releasing molecule 2 (CORM2)-induced HMOX1 on TNF-αproduction in both LPS-activated macrophages and in a murine endotoxin shock model69”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Nair, S. et al. Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. J. Exp. Med. 215, 1035–1045 (2018). source
Not checked in the free run.
- Premisecitation
No differences in IκBξ levels are observed between Irg1-/- and wildtype macrophages stimulated with LPS.
“no differences were observed in IκBξ levels between Irg1-/- and wildtype macrophages stimulated with LPS60.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- Interpretationcitation
Itaconate may dampen the immune response of Mtb-infected mice to limit immunopathology.
“These data suggest that itaconate may dampen the immune response of Mtb-infected mice to limit immunopathology.”
Quote in the paperSubstantial claim - Premisecitation
The selective inhibition of IL-6 by DI is mediated through inhibition of IκBξ.
“an effect shown to be mediated through inhibition of IκBξ the major transcription factor governing secondary transcriptional responses to TLR activation60.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- Premisecitation
1EI can inhibit IκBξ.
“1EI (an activated Michael acceptor) could also inhibit IκBξ”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- Premisecitation
The attenuation of IFN-β and ISGs by 4-OI is at least partially dependent on Nrf2.
“an effect that was at least partially dependent on Nrf259.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
DI induces electrophilic stress and Nrf2 in macrophages via depletion of intracellular GSH to form a DI-GSH adduct.
“Bambouskova and colleagues (2018) demonstrated that DI could induce electrophilic stress and Nrf2 in macrophages via depletion of intracellular GSH to form a DI-GSH adduct”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- Premisecitation
IRG1 suppresses production of TNF-α, IL-6 and IFN-β in LPS-tolerised BMDMs.
“IRG1 suppresses the production of the pro-inflammatory cytokines TNF-α, IL-6 and IFN-β in LPS-tolerised BMDMs67.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IκBξ–ATF3 inflammatory axis. Nature 556, 501–504 (2018). source
Not checked in the free run.
- Premisecitation
The effect of Irg1 on neutrophil recruitment is thought to be a consequence of itaconate-mediated transcriptional regulation of the inflammatory response.
“an effect thought to be a consequence of itaconate-mediated transcriptional regulation of the inflammatory response73.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] Brennan, M. S. et al. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One 10, e0120254 (2015). source
Not checked in the free run.
- Premisecitation
Irg1 impairs neutrophil recruitment to the lungs to curtail excessive lung inflammation and pathology.
“Irg1 was shown to specifically impair neutrophil recruitment to the lungs to curtail excessive lung inflammation and pathology”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] Brennan, M. S. et al. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One 10, e0120254 (2015). source
Not checked in the free run.
- Premisecitation
4-OI alkylates KEAP1 on several cysteine residues, including C151.
“4-OI was shown to alkylate KEAP1 on several cysteine residues, namely cysteine 151 (C151), a principal redox sensing cysteine important for activation of Nrf259,66.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- cites [66] Williams, J. O., Roche, T. E. & McFadden, B. A. Mechanism of action of isocitrate lyase from Pseudomonas indigofera. Biochemistry 10, 1384–1390 (1971). source
Not checked in the free run.
- Premisecitation
Induction of Irg1 and itaconate is largely dependent on autocrine/paracrine type I interferon signalling.
“the induction of Irg1 and itaconate was largely dependent on autocrine/paracrine type I interferon signalling59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
LPS-induced Nrf2 stabilisation is decreased in Irg1-deficient BMDMs.
“Bambouskova and colleagues (2018) who demonstrated a decrease in LPS-induced Nrf2 stabilisation in Irg1-deficient BMDMs”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- Premisecitation
IRG1 plays a major role in embryo implantation in the womb.
“it also appears to play a major role in embryo implantation in the womb, a process thought to require immunosuppression70–72.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [70] Ackermann, W. W. & Potter, V. R. Enzyme inhibition in relation to chemotherapy. Proc. Soc. Exp. Biol. Med. 72, 1–9 (1949). source
Not checked in the free run.
- cites [71] El Azzouny, M. et al. Dimethyl itaconate is not metabolized into itaconate intracellularly. J. Biol. Chem. 292, 4766–4769 (2017). source
Not checked in the free run.
- cites [72] Kobayashi, E. H. et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun. 7, 11624 (2016). source
Not checked in the free run.
- Premisecitation
The ability of 4-OI to induce NQO1 activity remains unaffected when pre-incubated with GSH.
“the ability of 4-OI to induce NQO1 activity remained unaffected59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Interpretationreasoning
Itaconate is likely central to macrophage function.
“the profound levels to which it is produced in macrophages suggest that it is likely to be central to macrophage function.”
Quote in the paperSubstantial claim - Premisecitation
Tumour-infiltrating macrophages release itaconate which potentiates tumour growth in peritoneal tumours (B16 melanoma and ID8 ovarian carcinoma).
“Most recently, an intriguing study in peritoneal tumours (B16 melanoma and ID8 ovarian carcinoma) has demonstrated that tumour-infiltrating macrophages release itaconate which potentiates tumour growth74.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] Saito, R. et al. Characterizations of three major cysteine sensors of Keap1 in stress response. Mol. Cell Biol. 36, 271–284 (2015). source
Not checked in the free run.
- Premisecitation
4EI cannot inhibit IκBξ unless GSH synthesis is inhibited by BSO.
“4EI (which has similar reactivity to endogenous itaconate) could not inhibit IκBξ unless GSH synthesis was inhibited by buthionine sulfoximine (BSO)60.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- Premisecitation
In LPS- and 4-OI-treated macrophages, several metabolic and inflammatory proteins are alkylated by 2,3-dicarboxypropylation.
“Furthermore, using a quantitative unbiased proteomic screen performed in both LPS (which will drive intracellular itaconate accumulation) and 4-OI-treated macrophages, several metabolic and inflammatory proteins were found to be alkylated representing the first demonstration of this novel post-translational modification (PTM), termed 2,3-dicarboxypropylation59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
Pre-treatment of LPS-activated macrophages with 4-OI significantly attenuates IFN-β levels and ISGs, including ISG20.
“pre-treatment of LPS-activated macrophages with 4-OI resulted in a significant attenuation of IFN-β levels and interferon-stimulated genes (ISGs), namely ISG20”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
Pre-treatment of LPS-activated BMDMs with 4-OI significantly attenuates IL-1β levels.
“Pre-treatment of LPS-activated BMDMs with 4-OI also resulted in a significant attenuation of IL-1β levels”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
Endogenous itaconate stabilizes Nrf2.
“confirming that endogenous itaconate stabilizes Nrf260.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- Premisecitation
The attenuation of IL-1β by 4-OI is largely abrogated in Nrf2-deficient macrophages.
“an effect that was largely abrogated in Nrf2-deficent macrophages59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
IRG1 is significantly increased in A20-deficient macrophages.
“IRG1 was also found to be significantly increased in A20-deficient macrophages”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113–117 (2018). source
Not checked in the free run.
- Premisecitation
In Mtb-infected Irg1-deficient mice, pro-inflammatory cytokine production including IL-6 and IL-1β is increased.
“Nair and colleagues (2018) convincingly demonstrated an increase in pro-inflammatory cytokine production, including IL-6 and IL-1β, in Mtb-infected Irg1-deficent mice”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] Brennan, M. S. et al. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One 10, e0120254 (2015). source
Not checked in the free run.
- Premisecitation
Increased IFN-β and IRF3 signaling is observed in LPS-tolerized Irg1-silenced macrophages.
“Yingke and colleagues (2013) also observed increased IFN-β and IRF3 signaling in LPS-tolerized Irg1-silenced macrophages”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IκBξ–ATF3 inflammatory axis. Nature 556, 501–504 (2018). source
Not checked in the free run.
- Premisecitation
Nrf2 can limit LPS-induced inflammatory gene transcription in a redox-independent manner through direct ligation of these genes and inhibition of RNA polymerase II recruitment.
“Nrf2 can also limit LPS-induced inflammatory gene transcription, in a redox-independent manner, through direct ligation of these genes and inhibition of RNA polymerse II recruitment47.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Xie, L. et al. First succinyl-proteome profiling of extensively drug-resistant Mycobacterium tuberculosis revealed involvement of succinylation in cellular physiology. J. Proteome Res. 14, 107–119 (2015). source
Not checked in the free run.
- Premisecitation
The effect of IRG1 on cytokine production is attributed to ROS-mediated induction of A20.
“Yingke and colleagues (2013) attributed the effect of IRG1 on cytokine production to ROS-mediated induction of A20”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IκBξ–ATF3 inflammatory axis. Nature 556, 501–504 (2018). source
Not checked in the free run.
- Premisecitation
Pre-treatment of control and LPS-activated macrophages with 4-OI significantly increases Nrf2 and Nrf2 target genes, including HMOX1.
“pre-treatment of control and LPS-activated macrophages with 4-OI still resulted in a significant increase in Nrf2 and Nrf2 target genes, namely Heme oxygenase 1 (HMOX1)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Premisecitation
The ability of DI to induce NQO1 activity is diminished when DI is pre-incubated with GSH.
“the ability of DI to induce NQO1 activity (a prototypical Nrf2 target gene) was diminished when pre-incubated with GSH”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Interpretationreasoning
Itaconate is unlikely to have physiological relevance to the canonical IκBξ-ATF3 pathway.
“it is unlikely to have any physiological relevance to this canonical pathway.”
Quote in the paperSubstantial claim - Premisecitation
MMF alters histone methylation with similarities to β-glucan-induced training.
“To determine the role of increased fumarate levels on the epigenetic landscape, Arts and colleagues (2016) used the cell permeable fumaric acid ester, monomethyl fumarate (MMF), which was shown to alter histone methylation with similarities to β-glucan induced training97.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
Not checked in the free run.
- Premisecitation
Fumarate can bind reactive thiol residues and inactivate KEAP1, leading to an antioxidant response.
“The first insights into the relevance of succination in HRLCC patients was proposed in 2011, when it was shown that fumarate could bind reactive thiol residues and inactivate KEAP1, the negative regulator of the master antioxidant transcription factor Nrf2, leading to a powerful antioxidant response81,82”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [81] Weiss, J. M. et al. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. J. Clin. Invest. 128, 3794–3805 (2018). source
Not checked in the free run.
- cites [82] Hall, C. J. et al. Immunoresponsive gene 1 augments bactericidal activity of macrophage-lineage cells by regulating β-oxidation-dependent mitochondrial ROS production. Cell. Metab. 18, 265–278 (2013). source
Not checked in the free run.
- Premisecitation
In vivo administration of HA inhibits development of EAE.
“Importantly, inhibition of aerobic glycolysis by the specific GAPDH inhibitor heptelidic acid (HA) and 2-deoxyglucose (2-DG) recapitulated the immunomodulatory effects of DMF in vitro, while in vivo administration of HA inhibited the development of experimental autoimmune encephalomyelitis (EAE), a murine model of MS99.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
Not checked in the free run.
- Premisecitation
ROS production in response to itaconate regulates Nrf2.
“Furthermore, Weiss and colleagues (2018) demonstrated that ROS production in response to itaconate regulates Nrf2”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
Not checked in the free run.
- Premisecitation
IRG1 (and presumably itaconate) levels are markedly increased in glioma tissue.
“Furthermore, IRG1 (and presumably itaconate) levels were also shown to be markedly increased in glioma tissue75.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
Not checked in the free run.
- Premisecitation
Mutations of FH cause Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC).
“However, in 2002 it was shown that mutations of FH are the cause of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), a cancer predisposition syndrome characterised by benign tumours of the smooth muscle of skin and uterus, and a very aggressive form of renal cancer78.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Cheon, Y. P., Xu, X., Bagchi, M. K. & Bagchi, I. C. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology 144, 5623–5630 (2003). source
Not checked in the free run.
- Premisecitation
Fumarate accumulates in LPS-activated macrophages.
“Outside of trained immunity, fumarate has previously been reported to accumulate in LPS-activated macrophages1,13.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
Not checked in the free run.
- cites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
Not checked in the free run.
- Premisecitation
Treatment with MMF augments TNF and IL-6 secretion in β-glucan-trained macrophages stimulated with LPS.
“Furthermore, treatment with MMF augmented TNF and IL-6 secretion in β-glucan-trained macrophages stimulated with LPS97.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
Not checked in the free run.
- Premisecitation
Accumulation of fumarate in β-glucan-treated monocytes is essential for trained immunity by enhancing cytokine production upon re-stimulation with LPS.
“Importantly, Arts and colleagues (2016) demonstrated that the accumulation of fumarate in β-glucan-treated monocytes was essential for trained immunity by enhancing cytokine production upon re-stimulation with LPS97.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
Not checked in the free run.
- Premisecitation
Accumulated fumarate can bind and inactivate reactive thiol residues of proteins and peptides in a process called succination.
“For instance, accumulated fumarate can bind and inactivate reactive thiol residues of proteins and peptides in a process called succination, a protein modification originally described in diabetes80.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Sherwin, J. R. et al. Identification of genes regulated by leukemia-inhibitory factor in the mouse uterus at the time of implantation. Mol. Endocrinol. 18, 2185–2195 (2004). source
Not checked in the free run.
- Premisecitation
Itaconate boosts OXPHOS and mtROS generation and subsequent MAPK activation in tumour-infiltrating macrophages.
“Itaconate was shown to boost OXPHOS and mtROS generation and subsequent MAPK activation in tumour-infiltrating macrophages (Figure 3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] Saito, R. et al. Characterizations of three major cysteine sensors of Keap1 in stress response. Mol. Cell Biol. 36, 271–284 (2015). source
Not checked in the free run.
- Premisecitation
A range of proteins regulating T cell function are sensitive to covalent modification by DMF, including PKCθ.
“By employing a proteomic approach the authors discovered a range of proteins which regulate T cell function that are sensitive to covalent modification by DMF including protein kinase C θ (PKCθ).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
Not checked in the free run.
- Premisecitation
The defining biochemical feature of FH loss is accumulation of fumarate.
“The defining biochemical feature of FH loss is the accumulation of fumarate, which has been implicated in tumorigenesis, acting as an oncometabolite79.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] Luan, H. H. & Medzhitov, R. Food fight: role of itaconate and other metabolites in antimicrobial defense. Cell. Metab. 24, 379–387 (2016). source
Not checked in the free run.
- Premisecitation
Jha et al 2015 described induction of an inflammatory argininosuccinate shunt linking the Krebs cycle to the Urea cycle.
“Using an integrated high-throughput transcriptional metabolic profiling and analysis pipeline (CoMBI-T), Jha and colleagues (2015) described the induction of an inflammatory argininosuccinate shunt, a metabolic pathway that links the Krebs cycle to the Urea cycle1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
Not checked in the free run.
- Premisecitation
Inhibition of aerobic glycolysis by HA and 2-DG recapitulates the immunomodulatory effects of DMF in vitro.
“Importantly, inhibition of aerobic glycolysis by the specific GAPDH inhibitor heptelidic acid (HA) and 2-deoxyglucose (2-DG) recapitulated the immunomodulatory effects of DMF in vitro, while in vivo administration of HA inhibited the development of experimental autoimmune encephalomyelitis (EAE), a murine model of MS99.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
Not checked in the free run.
- Interpretationreasoning
Itaconate serves as an example of crosstalk between macrophages and tumours in the context of metabolic reprogramming.
“As such, itaconate serves as another example of crosstalk between macrophages and tumours in the context of metabolic reprogramming.”
Quote in the paperNot a substantial claim - Premisecitation
TH1 and TH17 cells rely heavily on aerobic glycolysis.
“Two pro-inflammatory T cell subsets implicated in the pathogenesis of MS, namely TH1 and TH17 cells, rely heavily on aerobic glycolysis and treatment with DMF or MMF inhibited their development in vitro, as previously reported99,101,102, 49.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
Not checked in the free run.
- cites [101] Ooi, A. et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20, 511–523 (2011). source
Not checked in the free run.
- cites [102] Sullivan, L. B. et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol. Cell 51, 236–248 (2013). source
Not checked in the free run.
- Premisecitation
Treatment with DMF or MMF inhibits development of TH1 and TH17 cells in vitro.
“Two pro-inflammatory T cell subsets implicated in the pathogenesis of MS, namely TH1 and TH17 cells, rely heavily on aerobic glycolysis and treatment with DMF or MMF inhibited their development in vitro, as previously reported99,101,102, 49.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
Not checked in the free run.
- cites [101] Ooi, A. et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20, 511–523 (2011). source
Not checked in the free run.
- cites [102] Sullivan, L. B. et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol. Cell 51, 236–248 (2013). source
Not checked in the free run.
- Premisecitation
Endogenous fumarate succinates GAPDH in both mouse and human macrophages.
“Intriguingly, endogenous fumarate was also found to succinate GAPDH in both mouse and human macrophages, suggesting that elevated fumarate levels may act as an endogenous anti-inflammatory signal to limit inflammation, however, the precise role of fumarate accumulation remains an open question to be explored.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
Not checked in the free run.
- Premisecitation
Irg1 acts as an oncogene driving glioma pathogenesis.
“These data are consistent with previous reports demonstrating that Irg1 acts as an oncogene, driving glioma pathogenesis171.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [171] Osinalde, N. et al. Nuclear phosphoproteomic screen uncovers ACLY as mediator of IL-2-induced proliferation of CD4+ T lymphocytes. Mol. Cell. Proteomics 15, 2076–2092 (2016). source
Not checked in the free run.
- Premisecitation
Increased fumarate levels in β-glucan-treated monocytes are driven by enhanced shunting of glutamine into the TCA cycle (glutamine anaplerosis).
“Furthermore, increased fumarate levels were shown to be driven by enhanced shunting of glutamine into the TCA cycle, otherwise referred to as glutamine anaplerosis, as ascertained by a combination of biochemical techniques and the use of the glutaminase inhibitor, BPTES97.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
Not checked in the free run.
- Premisecitation
Induction of the argininosuccinate shunt occurs via an increase in Ass1 expression.
“Induction of this pathway occurred via an increase in the expression of argininosuccinate synthase (Ass1), which catalyses the formation of argininosuccinate from aspartate, citrulline and ATP98.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
Not checked in the free run.
- Premisecitation
Succination is a hallmark of FH-deficient tumours.
“Succination is a hallmark of FH-deficient tumours and an antibody against succinate protein has been proposed as a diagnostic marker for HLRCC89.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Delage, B. et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int. J. Cancer 126, 2762–2772 (2010). source
Not checked in the free run.
- Premisecitation
FH loss in renal cancer cells leads to increased DNA damage and resistance to ionising radiation due to fumarate-dependent inhibition of mitotic entry after IR even with unrepaired damage.
“It has also recently been shown that FH loss in renal cancer cells leads to increased DNA damage and resistance to ionising radiation (IR), due to a fumarate-dependent inhibition of mitotic entry after IR, even in the presence of unrepaired damage179.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [179] Zhang, J. et al. accumulation of succinate in cardiac ischemia primarily occurs via canonical Krebs cycle activity. Cell Rep. 23, 2617–2628 (2018). source
Not checked in the free run.
- Premisecitation
Fumarate-dependent oxidative stress drives renal cells to senescence in an FH-deficient mouse model.
“Of note, fumarate-dependent oxidative stress was shown to drive renal cells to senescence in an FH-deficient mouse model, and its bypass by the co-ablation of p21 increased malignant transformation in the kidneys503.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [503]
Not checked in the free run.
- Premisecitation
L-2-HG promotes tumour killing via CD8+ T cells.
“In addition to CD4+ T cells, an unexpected role for L-2-HG in the promotion of tumour killing acting via CD8+ T cells, cytotoxic T lymphocytes important for anti-tumour immunity, has emerged149.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
Not checked in the free run.
- Premisecitation
Fumarate inhibits a variety of α-KGDDs.
“As mentioned, fumarate also inhibits a variety of α-KGDDs, enzymes involved in multiple cellular processes, from metabolism to signalling and epigenetics90-92”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [90] Blewett, M. M. et al. Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells. Sci. Signal. 9, rs10 (2016). source
Not checked in the free run.
- cites [91] Angiari, S. & O’Neill, L. A. Dimethyl fumarate: targeting glycolysis to treat MS. Cell Res. 28, 613–615 (2018). source
Not checked in the free run.
- cites [92] Kornberg, M. D. et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360, 449–453 (2018). source
Not checked in the free run.
- Premisecitation
AOAA ameliorates disease progression in EAE.
“Lastly, AOAA ameliorated disease progression in EAE, a disease in which TH17 cells mediate pathology143.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
Not checked in the free run.
- Premisereasoning
Fumarate causes HIF stabilisation even under normoxic conditions (pseudohypoxia), a hallmark of FH-deficient tumours.
“Accordingly, fumarate causes HIF stabilisation, even under normoxic conditions, i.e. pseudohypoxia, a hallmark of FH-deficient tumours93.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [93] Brück, J., Dringen, R., Amasuno, A., Pau-Charles, I. & Ghoreschi, K. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis. Exp. Dermatol. 27, 611–624 (2018). source
Not checked in the free run.
- Premisecitation
Fumarate drives succination of Fe-S cluster biogenesis proteins, causing depletion of Fe-S clusters required for mitochondrial enzymes including complex I.
“Finally, it was shown that fumarate can drive succination of several members of the family of Iron Sulfur (Fe-S) cluster biogenesis proteins, causing a depletion of Fe-S clusters required for the activity of mitochondrial enzymes, including complex I88.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] Xiao, M. et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326–1338 (2012). source
Not checked in the free run.
- Premisecitation
A third 2HGA arises from germline mutations in SLC25A1, in which both enantiomers accumulate.
“A third 2HGA that arises from germline mutations in the mitochondrial citrate carrier SLC25A1, in which both enantiomers accumulate, has also been discovered.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [111] Yang, M., Soga, T., Pollard, P. J. & Adam, J. The emerging role of fumarate as an oncometabolite. Front. Oncol. 2, 85 (2012). source
Not checked in the free run.
- Premisecitation
Bypass of fumarate-dependent senescence by co-ablation of p21 increases malignant transformation in the kidneys.
“Of note, fumarate-dependent oxidative stress was shown to drive renal cells to senescence in an FH-deficient mouse model, and its bypass by the co-ablation of p21 increased malignant transformation in the kidneys503.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [503]
Not checked in the free run.
- Premisecitation
D-2-HG production is driven by conversion of glutamate to α-KG by GOT1.
“Mechanistically, D-2-HG production was driven by the conversion of glutamate to α-KG by the aspartate aminotransferase GOT1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
Not checked in the free run.
- Premisecitation
FH-deficient renal cancers are characterised by a distinct DNA hypermethylation phenotype affecting CDK2NA.
“Of note, FH-deficient renal cancers are characterised by a distinct DNA hypermethylation phenotype, which also affects the tumour suppressor CDK2NA85”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Frezza, C. Mitochondrial metabolites: undercover signalling molecules. Interface Focus 7, 20160100 (2017). source
Not checked in the free run.
- Premisecitation
Fumarate causes succination of IRP2, promoting transcription of transferrin.
“and also iron-responsive element binding protein (IRP)2, promting the transcription of transferrin87.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [87] Tomlinson, I. P. et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 30, 406–410 (2002). source
Not checked in the free run.
- Premisecitation
An antibody against succinate protein has been proposed as a diagnostic marker for HLRCC.
“Succination is a hallmark of FH-deficient tumours and an antibody against succinate protein has been proposed as a diagnostic marker for HLRCC89.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] Delage, B. et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int. J. Cancer 126, 2762–2772 (2010). source
Not checked in the free run.
- Premisecitation
Mutations in IDH1/2 are the most frequently mutated metabolic genes in human cancer.
“In recent years, two landmark genomic studies carried out in human glioma and acute myeloid leukaemia (AML) found mutations in IDH1/2 and it is now appreciated that these enzymes (which drive elevated production of D-2-HG) are the most frequently mutated metabolic genes in human cancer112-114.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [112] Sciacovelli, M. et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 537, 544–547 (2016). source
Not checked in the free run.
- cites [113] Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer 18, 128–134 (2018). source
Not checked in the free run.
- cites [114] Brat, D. J. et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481–2498 (2015). source
Not checked in the free run.
- Premisecitation
D-2-HG levels are increased in TH17 cells compared to iTreg cells.
“Interestingly, Xu and colleagues (2017) observed increased levels in of D-2-HG in TH17 cells, when compared to iTreg cells143.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
Not checked in the free run.
- Premisecitation
Fumarate accumulation inhibits TET-dependent DNA demethylation of the miR200 family, promoting EMT.
“It has also been shown that fumarate accumulation leads to the inhibition of TET-dependent DNA demethylation of a class of antimetastatic miRNAs, the miR200 family, promoting an EMT95”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] Zheng, L. et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat. Commun. 6, 6001 (2015). source
Not checked in the free run.
- Premisecitation
Fumarate causes succination of mitochondrial aconitase ACO2, leading to truncation of the TCA cycle.
“Fumarate was shown to cause succination of the mitochondrial aconitase, ACO2, leading to an additional truncation of the TCA cycle86”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86] Arts, R. J. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell. Metab. 24, 807–819 (2016). source
Not checked in the free run.
- Premisecitation
iTreg cells do not require HIF-1α.
“On the other hand, induced regulatory T (iTreg) cells, also derived from naïve CD4+ T cells, do not require HIF-1α143,146.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
Not checked in the free run.
- cites [146] Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 17, 510–522 (2010). source
Not checked in the free run.
- Premisecitation
In IDH1/2-mutant gliomas, D-2-HG accumulates to levels up to 35 mM.
“In IDH1/2-mutant gliomas, D-2-HG has been reported to accumulate to levels up to 35 mM, as such, D-2-HG could inhibit α-KG-dependent dioxygenases to affect alternative cellular signaling pathways120.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Chalmers, R. A. et al. d-2-hydroxyglutaric aciduria: case report and biochemical studies. J. Inherit. Metab. Dis. 3, 11–15 (1980). source
Not checked in the free run.
- Premisecitation
Exogenous treatment of CD8+ T cells with L-2-HG enhances in vivo proliferation, persistence and anti-tumour capacity of adoptively transferred CD8+ T cells.
“Furthermore, exogenous treatment of CD8+ T cells with L-2-HG greatly enhanced the in vivo proliferation, persistence and anti-tumour capacity of adoptively transferred CD8+ T cells149.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
Not checked in the free run.
- Interpretationreasoning
L-2HG may assist with hypoxic adaptation.
“Functionally, L-2HG is both sufficient to try histone methylation, in particular histone 3 lysine 9 (H3K9me3), and can also promote HIF-1α stabilization in normoxia and therefore may assist with hypoxic adaptation.”
Quote in the paperSubstantial claim - Premisecitation
D-2-HG produced by mIDH1/2 drives a CpG island methylator phenotype in glioma and ICC tumours to promote tumorigenesis.
“D-2-HG produced by mIDH1/2 has been shown to drive a CpG island methylator phenotype (G-CIMP) in both glioma and ICC tumours to promote tumorigenesis, and has also been found to occupy the active site of histone demethylases thereby increasing histone methylation in primary gliomas121,123-125.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
Not checked in the free run.
- cites [123] Rzem, R. et al. A gene encoding a putative FAD-dependent l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc. Natl. Acad. Sci. USA 101, 16849–16854 (2004). source
Not checked in the free run.
- cites [124] Struys, E. A. et al. Mutations in the d-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 76, 358–360 (2005). source
Not checked in the free run.
- cites [125] Topçu, M. et al. l-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum. Mol. Genet. 13, 2803–2811 (2004). source
Not checked in the free run.
- Premisecitation
The IC50 of D-2-HG toward KDM family members is in the low micromolar range (24-106 μM).
“Although the IC50 of D-2-HG toward KDM family members is in the low micromolar range (24-106 μM), it can also inhibit FIH and PHD2, with IC50 values of 1.5 and 7.3 mM, respectively121.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
Not checked in the free run.
- Premisecitation
Accumulation of L-2-HG alters CD8+ T cell differentiation through modulation of histone and DNA methylation and HIF stability.
“Accumulation of L-2-HG altered CD8+ T cell differentiation through modulation of both the histone and DNA methylation landscape of the cell, and also via HIF stability149.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
Not checked in the free run.
- Interpretationcitation
D-2-HG drives tumorigenesis through promotion of genetic instability, predisposing cells to oncogenic transformation.
“another possible mechanism by which D-2-HG drives tumorigenesis is through the promotion of genetic instability, predisposing cells to oncogenic transformation103.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Linehan, W. M. et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374, 135–145 (2016). source
Not checked in the free run.
- Premisecitation
The most common cancers thought to arise from mutant IDH1/2 include glioma, cartilaginous tumours, AML, AITL and ICC.
“The most commonly occurring cancers thought to arise from mutant IDH1/2 (mIDH1/2) include glioma, cartilaginous tumours, AML, angioimmunoblastic T cell lymphoma (AITL) and intrahepatic cholangiocarcinoma (ICC).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Linehan, W. M. et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374, 135–145 (2016). source
Not checked in the free run.
- Premisecitation
Under hypoxia, L-2HG is selectively produced by mammalian cells.
“It has been reported that under conditions of hypoxia L-2HG is selectively produced by mammalian cells 51.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Du, J. et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806–809 (2011). source
Not checked in the free run.
- Premisecitation
D-2-HG inhibits α-KG-dependent ALKBH2 and ALKBH3, DNA damage repair enzymes that detoxify 1-methyladenine and 3-methylcytosine lesions.
“D-2-HG has been shown to inhibit α-KG-dependent alkylation repair homologs, ALKBH2 and ALKBH3, critical DNA damage repair enzymes that detoxify 1-methyladenine (1 mA) and 3-methlycytosine (3mC) lesions in DNA derived from alkylating agents121,131.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
Not checked in the free run.
- cites [131] MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259–283 (2013). source
Not checked in the free run.
- Premisecitation
D-2-HG produced by mIDH1 in low grade glioma activates mTOR signaling.
“D-2-HG produced by mIDH1 in low grade glioma was found to activate mechanistic target of rapamycin (mTOR) signaling133.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Xu, T. et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548, 228–233 (2017). source
Not checked in the free run.
- Premisecitation
D-2-HG destabilises DEPTOR, a negative regulator of mTORC1/2, partly through inhibition of histone demethylase KDM4A.
“Mechanistically, it was proposed that D-2-HG destabilised DEPTOR, a negative regulator of mTORC1/2 partly through inhibition of the histone demethylase KDM4A133.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Xu, T. et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548, 228–233 (2017). source
Not checked in the free run.
- Premisecitation
HIF-1α stabilisation occurs in IDH1-mutant brain tissue.
“Indeed, D-2-HG accumulation in IDH-mutant glioma has been found to inhibit PHD hydroxylase and stabilise HIF-1α126 and HIF-1αstabilisation has been shown to occur in IDH1-mutant brain tissue127.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [127] Nota, B. et al. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined d-2- and l-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 92, 627–631 (2013). source
Not checked in the free run.
- Premisecitation
Metabolomic profiling of mIDH1/2 gliomas revealed significant alterations in cellular metabolism, recapitulated by exogenous D-2-HG.
“metabolomic profiling of mIDH1/2 gliomas revealed significant alterations in cellular metabolism, an effect recapitulated with the exogenous addition of D-2-HG134.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134] Figueroa, M. E. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 18, 553–567 (2010). source
Not checked in the free run.
- Premisecitation
D-2-HG acts as a competitive inhibitor of α-KGDDs including TET family and JMJD family.
“As with succinate and fumarate, D-2-HG acts as a competitive inhibitor of α-KGDDs including, but not limited to, the TET family and JMJD family of DNA and histone demethylases, respectively121,22.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
Not checked in the free run.
- cites [22] Epstein, A. C. R. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001). source
Not checked in the free run.
- Premisecitation
L-2HG is a potent inhibitor of α-KG-dependent enzymes.
“L-2HG is also a potent inhibitor of α-KG-dependent enzymes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Du, J. et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806–809 (2011). source
Not checked in the free run.
- Premisecitation
L-2-HG levels increase up to 1.5 mM in response to T-cell receptor triggering in mouse CD8+ T cells.
“Interestingly, Tyrakis and colleagues (2016) observed a dramatic increase in L-2-HG levels, reaching up to 1.5 mM, in response to T-cell receptor triggering in mouse CD8+ T cells149.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
Not checked in the free run.
- Premisecitation
During adipocyte differentiation, global histone acetylation is determined by glucose availability through an ACL-dependent pathway.
“It was shown that during adipocyte differentiation, global histone acetylation is determined by glucose availability through an ACL-dependent pathway 54.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
Not checked in the free run.
- Premisecitation
ACLY is phosphorylated in response to IL-2 treatment in CD4+ T-lymphocytes.
“An unbiased mass spectrometry-based study of the nuclear phosphoproteome of resting and IL-2-treated CD4+ T-lymphocytes revealed that ACLY is phosphorylated in response to IL-2 treatment 57.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] Meiser, J. et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J. Biol. Chem. 291, 3932–3946 (2016). source
Not checked in the free run.
- Interpretationreasoning
Multiple mechanisms involving acetyl-CoA may exist to regulate Ifng expression.
“Multiple mechanisms involving acetyl-CoA may therefore exist to regulate Ifng expression.”
Quote in the paperNot a substantial claim - Interpretationcitation
Histone acetylation levels might be a valuable biomarker to predict tumor relapse.
“These data suggest that histone acetylation levels might be a valuable biomarker to predict tumor relapse.”
Quote in the paperSubstantial claim - Premisecitation
Histone acetylation and phosphorylated Akt levels correlate significantly in human glioma and human prostate cancer.
“histone acetylation and phosphorylated Akt levels correlate significantly in human glioma and human prostate cancer”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Németh, B. et al. Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage. FASEB J. 30, 286–300 (2016). source
Not checked in the free run.
- Premisecitation
Inhibiting SDH during ischaemia by preloading tissues with DMM prevents succinate accumulation during ischaemia and protects against tissue damage upon reperfusion.
“Inhibiting the mitochondrial enzyme SDH during ischaemia by preloading tissues with the SDH inhibitor DMM prevented succinate accumulation during ischaemia and protected against tissue damage upon reperfusion150.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [150] Zhao, S. et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α. Science 324, 261–265 (2009). source
Not checked in the free run.
- Interpretationreasoning
Initiation and pathogenesis of IDH-mutant tumours may share parallels with SDH-mutant tumours.
“As such, the initiation and pathogenesis of IDH-mutant tumours may share parallels with SDH-mutant tumours.”
Quote in the paperSubstantial claim - Premisecitation
Succinate accumulates during ischaemia and is oxidised upon reperfusion to drive mitochondrial superoxide formation that contributes to ischaemia-reperfusion injury.
“succinate accumulated during ischaemia and is then oxidised upon reperfusion to drive the mitochondrial superoxide formation that contributes to ischaemia-reperfusion (IR) injury150,151.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [150] Zhao, S. et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α. Science 324, 261–265 (2009). source
Not checked in the free run.
- cites [151] Intlekofer, A. M. et al. Hypoxia induces production of l-2-hydroxyglutarate. Cell Metab. 22, 304–311 (2015). source
Not checked in the free run.
- Premisecitation
LDHA is induced in activated T cells and enhances histone acetylation of Ifng via maintenance of acetyl-CoA levels to promote its expression.
“The authors demonstrate that LDA, an enzyme that catalyzes the reversible conversion of pyruvate and NADH to lactate and NAD+, is induced in activated T cells and enhances histone acetylation of interferon gamma (Ifng) via the maintenance of acetyl-CoA levels to promote its expression 55.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
Not checked in the free run.
- Premisecitation
A portion of succinate that accumulates during ischemia and inflammation is released from the cell into the extracellular environment.
“a portion of the succinate that accumulates during ischemia and inflammation is released from the cell into the extracellular environment through poorly defined processes. This occurs following IR injury158,159, inflammation10, or cold exposure160.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [158] Carbonneau, M. et al. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat. Commun. 7, 12700 (2016). source
Not checked in the free run.
- cites [159] Reitman, Z. J. et al. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc. Natl. Acad. Sci. USA 108, 3270–3275 (2011). source
Not checked in the free run.
- cites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
Not checked in the free run.
- cites [160] Chesnelong, C. et al. Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro-Oncol. 16, 686–695 (2014). source
Not checked in the free run.
- Interpretationcitation
Cellular reprogramming elicited by D-2-HG may play a prominent role in the pathogenesis of IDH-mutant tumours.
“all suggesting that cellular reprogramming elicited by D-2-HG may play a prominent role in the pathogenesis of IDH-mutant tumours135-137.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [135] Losman, J. A. et al. R-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339, 1621–1625 (2013). source
Not checked in the free run.
- cites [136] Tyrakis, P. A. et al. S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. Nature 540, 236–241 (2016). source
Not checked in the free run.
- cites [137] Doedens, A. L. et al. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen. Nat. Immunol. 14, 1173–1182 (2013). source
Not checked in the free run.
- Interpretationcitation
Released succinate likely acts as an inflammatory signal via SUCNR1.
“one likely role is as an inflammatory signal, acting via SUCNR14,5,161,162.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
Not checked in the free run.
- cites [5] Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261–1269 (2008). source
Not checked in the free run.
- cites [161] Grassian, A. R. et al. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Res. 74, 3317–3331 (2014). source
Not checked in the free run.
- cites [162] Izquierdo-Garcia, J. L. et al. IDH1 mutation induces reprogramming of pyruvate metabolism. Cancer Res. 75, 2999–3009 (2015). source
Not checked in the free run.
- Interpretationcitation
Suppression of RIP3-mediated necroptosis and MLK3-mediated apoptosis by D-2-HG may contribute to IDH-mutant carcinogenesis.
“These findings therefore suggest that both suppression of RIP3-mediated necroptosis and MLK3-mediated apoptosis by D-2-HG may contribute to IDH-mutant carcinogenesis140,141.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [140] Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149–1153 (2009). source
Not checked in the free run.
- cites [141] Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009). source
Not checked in the free run.
- Premisecitation
Pharmacological or genetic ablation of ACLY impairs IL-2-promoted T-cell growth.
“Pharmacological or genetic ablation of ACLY function impaired IL-2-promoted T-cell growth.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] Meiser, J. et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J. Biol. Chem. 291, 3932–3946 (2016). source
Not checked in the free run.
- Premisecitation
DMM decreases inflammation in a mouse model of sepsis.
“DMM could also decrease inflammation in a mouse model of sepsis28.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Rasola, A., Neckers, L. & Picard, D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 24, 455–463 (2014). source
Not checked in the free run.
- Premisecitation
Acetyl-CoA levels and histone acetylation in tumors are regulated by oncogenic activation of Akt and subsequent ACLY phosphorylation.
“In 2014 Lee and colleagues demonstrated that acetyl-CoA levels and histone acetylation in tumors are regulated by oncogenic activation of Akt and subsequent ACLY phosphorylation58.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Németh, B. et al. Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage. FASEB J. 30, 286–300 (2016). source
Not checked in the free run.
- Premisecitation
Lower histone acetylation levels are predictive of worse outcome in human glioma and prostate cancer.
“levels of histone acetylation have been shown to be predictive of which patients would later exhibit biochemical failure, with lower levels predictive of worse outcome.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Németh, B. et al. Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage. FASEB J. 30, 286–300 (2016). source
Not checked in the free run.
- Interpretationreasoning
Simple molecules designed to inhibit SDH are a novel class of anti-inflammatory and anti-IR injury compounds.
“Hence, simple molecules designed to inhibit SDH are a novel class of anti-inflammatory and anti-IR injury compounds.”
Quote in the paperSubstantial claim - Premisecitation
Malonate is protective when added at reperfusion.
“Malonate itself was also protective when added at reperfusion152,153.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [152] Intlekofer, A. M. et al. l-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH. Nat. Chem. Biol. 13, 494–500 (2017). source
Not checked in the free run.
- cites [153] Nadtochiy, S. M. et al. Acidic pH Is a metabolic switch for 2-hydroxyglutarate generation and signaling. J. Biol. Chem. 291, 20188–20197 (2016). source
Not checked in the free run.
- Premisecitation
Cells depleted of ACL contain less lipid than control cells.
“Cells depleted of ACL contained visibly less lipid than control cells.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
Not checked in the free run.
- Premisecitation
ACLY, acetyl-CoA levels and histone acetylation play an important role in the DNA damage response in tumor cells.
“ACLY, acetyl-CoA levels and histone acetylation have also been shown to play an important role in the DNA damage response in tumor cells 59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- Interpretationcitation
Simple inhibitors of Krebs cycle enzymes could be used to prevent pathological damage.
“This work indicated that simple inhibitors of Krebs cycle enzymes could be used to prevent pathological damage.”
Quote in the paperSubstantial claim - Premisecitation
Itaconate primarily acts as a protective, anti-inflammatory metabolite.
“The generation of itaconate from the Krebs Cycle intermediate cis-aconitate contrasts with most other metabolite signals emanating from mitochondria, in that it primarily acts as a protective, anti-inflammatory metabolite55,59,60.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
Not checked in the free run.
- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- Premisecitation
In vivo administration of DI ameliorates skin pathology in a mouse model of psoriasis.
“The therapeutic potential of DI was also demonstrated as in vivo administration of DI resulted in an amelioration of skin pathology in a mouse model of psoriasis, a disease also currently treated by the related electrophile DMF60,65.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- cites [65] Naujoks, J. et al. IFNs modify the proteome of Legionella-containing vacuoles and restrict infection via IRG1-derived itaconic acid. PLoS Pathog. 12, e1005408 (2016). source
Not checked in the free run.
- Interpretationcitation
The emerging role of Krebs cycle intermediates opens the possibility of manipulating levels and impacts of mitochondrial metabolites within the matrix, the rest of the cell, or after release into circulation.
“the emerging role of Krebs cycle intermediates in many central biomedical pathways opens up the possibility of extending mitochondrial pharmacology164-167 to manipulating the levels and impacts of mitochondrial metabolites both within the matrix, the rest of the cell, or following their release from the cell into the circulation.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [164] Li, F. et al. NADP+–IDH mutations promote hypersuccinylation that impairs mitochondria respiration and induces apoptosis resistance. Mol. Cell 60, 661–675 (2015). source
Not checked in the free run.
- cites [165] Jiang, B. et al. IDH1 mutation promotes tumorigenesis by inhibiting JNK activation and apoptosis induced by serum starvation. Cell Rep. 19, 389–400 (2017). source
Not checked in the free run.
- cites [166] Yang, Z. et al. 2-HG inhibits necroptosis by stimulating DNMT1-dependent hypermethylation of the RIP3 promoter. Cell Rep. 19, 1846–1857 (2017). source
Not checked in the free run.
- cites [167] Kurdistani, S. K. & Grunstein, M. Histone acetylation and deacetylation in yeast. Nat. Rev. Mol. Cell Biol. 4, 276–284 (2003). source
Not checked in the free run.
- May combine two claims. 98
- Classified as probably not a substantial claim. 7
May combine two claims.
PremisecitationHIF-1 binds hypoxia response elements in target genes and increases expression of glycolytic enzymes and glucose transporters GLUT1 and GLUT3.
“HIF-1 binds to hypoxia response elements (HREs) in target genes and increases the expression of numerous glycolytic enzymes and the glucose transporters (GLUT)1 and GLUT3.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLPS-induced succinate inhibits PHD activity in macrophages directly and indirectly via ROS, resulting in stabilization of HIF-1α.
“Analogous to tumours, LPS-induced succinate was shown to both directly and indirectly (via ROS) inhibit PHD activity in macrophages resulting in stabilization of HIF-1α2.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
Not checked in the free run.
May combine two claims.
PremisecitationTRAP1 is highly expressed in many tumors and decreases SDH activity, causing succinate accumulation.
“An additional mechanism by which succinate accumulates tumors involves the mitochondrial chaperone, tumor necrosis factor receptor-associated protein 1 (TRAP1) which is highly expressed in many tumors22. TRAP1 decreases SDH activity and succinate accumulates as a result.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Epstein, A. C. R. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001). source
Not checked in the free run.
May combine two claims.
PremisecitationIn the presence of oxygen, conserved proline residues in HIF-1α are hydroxylated by PHD 1, 2 and 3, providing a recognition site for VHL E3 ubiquitin ligase, which ubiquitinates HIF-1α and targets it for proteasomal degradation.
“In the presence of oxygen, conserved proline residues in the HIF-1α subunit are hydroxylated by PHD 1, 2 and 3 16. Hydroxylation provides a recognition site for the binding of Von Hippel-Lindau (VHL) E3 ubiquitin ligase, which ubiquitinates HIF-1α and subsequently targets it for proteasomal degradation17.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [16] Peruzzotti-Jametti, L. et al. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation. Cell Stem Cell 22, 355–368.e13 (2018). source
Not checked in the free run.
- cites [17] Bhuniya, D. et al. Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg. Med. Chem. Lett. 21, 3596–3602 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationSUCNR1 is highly expressed in mouse kidney, liver, spleen, small intestine, and on dendritic cells, and ligand binding induces Gi and Gq signalling cascades.
“SUCNR1 is highly expressed in mouse kidney, liver, spleen, small intestine3, and on dendritic cells (DCs) 4 and ligand binding induces Gi and Gq signalling cascades3.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [3] He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188–193 (2004). source
Not checked in the free run.
- cites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
Not checked in the free run.
May combine two claims.
PremisecitationExtracellular succinate acts in synergy with TLR ligands to increase TNFα and IL-1β expression and increases the capacity of DCs to act as antigen presenting cells.
“Extracellular succinate addition also acts in synergy with TLR ligands to increase TNFα and IL-1β expression4 and increases the capacity of DCs to act as antigen presenting cells.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSuccinate is elevated in plasma after acute exercise and in marathon runners.
“Specifically, succinate is elevated in plasma after acute exercise and in marathon runners175.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [175] Sivanand, S. et al. Nuclear acetyl-CoA production by ACLY promotes homologous recombination. Mol. Cell 67, 252–265.e56 (2017). source
Not checked in the free run.
May combine two claims.
PremisecitationSuccinate acts through direct generation of mitochondrial ROS, activation of HIF-1α, and ligation of SUCNR1 to exert inflammatory effects.
“succinate has been shown to act through several pathways to exert its inflammatory effects: through direct generation of mitochondrial ROS (mtROS), by activation of hypoxia-inducible factor-1alpha (HIF-1α; discussed below), and by through ligation of the G-protein coupled receptor succinate receptor 1 (SUCNR1).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn a mouse model of multiple sclerosis, transplantation of neural stem cells reduces succinate levels in the cerebrospinal fluid and decreases infiltration of damaging macrophages and microglial cells.
“In a mouse model of multiple sclerosis (MS) transplantation of neural stem cells (NSCs) reduced succinate levels in the cerebrospinal fluid and thereby decreased infiltration of damaging macrophages and microglial cells10.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationSuccinate and α-KG act as ligands for the orphan G-protein coupled receptors GPR91 (now SUCNR1) and GPR99 (now OXGR1), respectively.
“He and colleagues made an important discovery when they found that the Krebs cycle-derived metabolites, succinate and α-KG, acted as ligands for the orphan G-protein coupled receptors GPR91 (now known as SUCNR1) and GPR99 (now known as OXRG1), respectively3.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188–193 (2004). source
Not checked in the free run.
May combine two claims.
PremisecitationIn limited oxygen, HIF-1α degradation is prevented, allowing translocation to the nucleus, dimerization with HIF-1β and binding of target genes.
“This degradation is prevented in conditions of limited oxygen, allowing for HIF-1α translocation to the nucleus, dimerization with HIF-1β and binding of target genes13.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
Not checked in the free run.
May combine two claims.
PremisecitationSuccinate acts as a hypertensive agent, modulating the renin-angiotensin system via SUCNR1 signalling, independent of its role in bioenergetics.
“The authors demonstrated that succinate acted as an important hypertensive agent, modulating the renin-angiotensin system via SUCNR1 signalling, independent of its role in bioenergetics3.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188–193 (2004). source
Not checked in the free run.
May combine two claims.
PremisecitationROS impair the activity of FIH, which hydroxylates an asparagine residue in HIF-1α and decreases transcriptional activity.
“ROS also impair the activity of Factor Inhibiting HIF (FIH), another member of the α-KGDD family25, which hydroxylates an asparagine residue in the carboxy terminal of HIF-1α resulting in a decrease in transcriptional activity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] Frede, S., Stockmann, C., Freitag, P. & Fandrey, J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB. Biochem. J. 396, 517–527 (2006). source
Not checked in the free run.
May combine two claims.
PremisecitationSuccinate is a pro-inflammatory metabolite that accumulates in LPS/IFN-γ-treated macrophages.
“Recent data indicate that succinate is a pro-inflammatory metabolite that accumulates in LPS/IFN-γ-treated macrophages1,2.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
Not checked in the free run.
- cites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
Not checked in the free run.
May combine two claims.
PremisecitationLigation of SUCNR1 on neural stem cells upregulates the dicarboxylate co-transporter Slc13a3/5, correlating with increased succinate uptake by the NSCs.
“Mechanistically, ligation of SUCNR1 on the surface of NSCs upregulates the expression of the dicarboxylate co-transporter Slc13a3/5, which correlates with increased uptake by the NSCs thereby scavenging succinate away from pro-inflammatory immune cells.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationROS stabilize HIF-1α by inducing non-enzymatic decarboxylation of α-KG and by oxidizing Fe2+ to Fe3+.
“ROS-can stabilize HIF-1α by inducing non-enzymatic decarboxylation of α-KG24 and by oxidizing iron (Fe2+) to Fe3+, two required PHD co-factors25.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24] Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633–643 (2013). source
Not checked in the free run.
- cites [25] Frede, S., Stockmann, C., Freitag, P. & Fandrey, J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB. Biochem. J. 396, 517–527 (2006). source
Not checked in the free run.
May combine two claims.
Premisenone givenIn the absence of SUCNR1, a reduction in absolute numbers of macrophages, but not inflammatory signalling, is observed and this improves adipose tissue inflammation and glucose tolerance in mice following high-fat diet feeding.
“In the absence of SUCNR1 a reduction in absolute numbers of macrophages, but not inflammatory signalling, was observed and this resulted in an improvement in adipose tissue inflammation and improved glucose tolerance in mice following high-fat diet feeding.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSuccinate inhibits the PHDs via product inhibition and stabilizes HIF-1α.
“The PHDs generate succinate from α-KG, and importantly succinate (acting via product inhibition) will inhibit the PHDs and stabilize HIF-1α21.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] Semenza, G. L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24, 97–106 (2009).
Not checked in the free run.
May combine two claims.
PremisecitationFollowing LPS treatment, both intracellular succinate levels and cell surface expression of SUCNR1 are increased.
“Following LPS treatment both intracellular succinate levels and the cell surface expression of SUCNR1 are increased.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261–1269 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationLysine succinylation is caused by accumulation of succinyl-CoA, which can result from SDH inhibition and succinate accumulation.
“This modification is caused by the accumulation of succinyl-CoA, which can result from SDH inhibition and succinate accumulation38.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] Jin, Z., Wei, W., Yang, M., Du, Y. & Wan, Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell. Metab. 20, 483–498 (2014). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningComplex I of the electron transport chain is an important site of ROS production in macrophages and such ROS production may depend on reverse electron transport.
“These data suggest that complex I of the ETC is an important site of ROS production in macrophages and such ROS production may depend on RET.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningSuccinate can have profound impacts on cellular function acting intracellularly via ROS and HIF-1α, succinylation and histone and DNA modification and extracellularly via SUCNR1.
“These data demonstrate that succinate can have profound impacts on cellular function acting both intracellularly via ROS and HIF-1α, succinylation and histone and DNA modification and extracellularly via SUCNR1.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTraining with β-glucan is protective against Staphylococcus aureus infection and this effect is abrogated in HIF-1α-deficient mice.
“Training with β-glucan was shown to be protective against Staphylococcus aureus infection and this effect was abrogated in HIF-1α-deficient mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] El-Khoury, R. et al. Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br. J. Pharmacol. 171, 2243–2249 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationSIRT5 desuccinylates and activates PKM2 and limits IL-1β production.
“The authors demonstrate that SIRT5 desuccinylates and activates PKM2 and this limits IL-1β production.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Zhang, Z. et al. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 7, 58–63 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationDI potently induces Nrf2 and several Nrf2 target genes in control and LPS-activated BMDMs.
“DI was first employed as an experimental tool and was shown to potently induce Nrf2 and several Nrf2 target genes in control and LPS-activated BMDMs59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationItaconate modulates inflammation by competitively inhibiting SDH and succinate oxidation.
“Lampropoulou and colleagues (2016) suggested that mechanistically the ability of itaconate to modulate inflammation arose from its ability to competitively inhibit SDH and succinate oxidation50.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationThis potentiation requires both succinate oxidation by SDH and an increase in mitochondrial membrane potential.
“This requires both succinate oxidation by the enzyme succinate dehydrogenase (SDH) and an increase in mitochondrial membrane potential.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
Not checked in the free run.
- cites [30] Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S. & Schumacker, P. T. Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol. Cell. Biol. 28, 718–731 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationItaconate is an important immunomodulatory metabolite that negatively regulates the inflammatory response and cytokine production.
“Since 2016, several key studies have uncovered a role for itaconate as a crucial anti-inflammatory metabolite that negatively regulates the inflammatory response and cytokine production50,59–61, as shown in Figure 3.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
Not checked in the free run.
- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- cites [61] Shin, J. H. et al. 1H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J. Proteome Res. 10, 2238–2247 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationIrg1-deficient BMDMs exhibit a significant increase in production of IL-12, IL-6, NO, and under NLRP3 inflammasome-activating conditions, increased IL-1β and IL-18.
“Furthermore, Irg1-deficient BMDMs, whereby genetic deletion of Irg1 completely abolished itaconate synthesis, exhibited a significant increase in the production of IL-12, IL-6, NO, and under conditions that activate the NLRP3 inflammasome, increased IL-1β and IL-1850.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationLPS-induced HIF-1α not only promotes glycolysis but is also directly pro-inflammatory.
“LPS-induced HIF-1α not only promotes glycolysis but is also directly pro-inflammatory.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSustained induction of IL-1β in response to LPS requires HIF-1α and occurs under normoxia.
“The sustained induction of IL-1β in response to LPS was shown to require HIF-1α and to occur under normoxia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
Not checked in the free run.
May combine two claims.
PremisecitationSirT5 has potent desuccinylase and demalonylase activity.
“SirT5, which was previously thought to function primarily as a deacetylase has been shown to have potent desuccinylase activity 44.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Cheng, S. C. et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014). source
Not checked in the free run.
May combine two claims.
PremisereasoningLimiting succinate oxidation with dimethylmalonate represses LPS-induced HIF-1α, IL-1β and ROS and boosts IL-10 and IL-1RA.
“Limiting succinate oxidation with the pro-drug dimethylmalonate (DMM), which releases malonate that inhibits SDH function, profoundly represses LPS-induced HIF-1α, IL-1β and ROS and boosts IL-10 and IL-1RA.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSuccinylation is evolutionarily conserved and its substrates are numerous, including proteins involved in cellular metabolism.
“Western blot analysis of whole cell lysates revealed that this modification is evolutionarily conserved and that substrates are numerous39 and include proteins involved in cellular metabolism38.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [38] Jin, Z., Wei, W., Yang, M., Du, Y. & Wan, Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell. Metab. 20, 483–498 (2014). source
Not checked in the free run.
- cites [39] Murphy, M. P. How mitochondria produce reactive oxygen species. Biochem. J. 417, 1–13 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationItaconate is an α,β-unsaturated carbonyl compound and a potential Michael acceptor that could undergo nucleophilic attack by the thiolate ion of protein cysteine residues.
“It is also important to note that itaconate is an α,β-unsaturated carbonyl compound, making it a potential Michael acceptor that could undergo nucleophilic attack by the thiolate ion of protein cysteine residues, as such the methyl esterification of the proximal carboxyl group conjugated to the alkene would be predicted to increase the electrophilicity of itaconate63.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Michelucci, A. et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc. Natl. Acad. Sci. USA. 110, 7820–7825 (2013). source
Not checked in the free run.
May combine two claims.
PremisecitationTraining with β-glucan induces epigenetic upregulation of glycolytic genes including HIF-1α, hexokinase and pyruvate kinase and increases succinate levels.
“Interestingly, in addition to potentiating cytokine production in response to LPS, training with β-glucan induced epigenetic upregulation of genes involved in glycolysis such as HIF-1α, Hexokinase (HK) and pyruvate kinase and increased succinate levels37.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] El-Khoury, R. et al. Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br. J. Pharmacol. 171, 2243–2249 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationLoss of HIF-1α in macrophages decreases TNF-α, IL-1β and IL-1α production but does not affect production of IL-4 or IL-10.
“The loss of HIF-1α in macrophages decreased TNF-α, IL-1β and IL-1α production, but did not affect production of the anti-inflammatory cytokines IL-4 or IL-10 29.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Mu, X. et al. Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget 8, 13174–13185 (2017). source
Not checked in the free run.
May combine two claims.
PremisecitationInhibition of IκBξ by DI is mediated by activation of ATF3 and occurs at the level of Nfkbiz translation, as assessed by eIF2α phosphorylation, in a Nrf2-independent manner.
“inhibition of IκBξ by DI was shown to be mediated by activation of the transcription factor ATF3 and occur at the level of Nfkbiz translation, as assessed by eIF2α phosphorylation, in a Nrf2-independent manner60.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
May combine two claims.
PremisecitationSupplementation of ROS in Irg1-deficient BMDMs increases A20 expression and abolishes the break of endotoxin tolerance.
“Supplementation of ROS in Irg1-deficient BMDMs increased A20 expression and abolished the break of endotoxin tolerance67.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IκBξ–ATF3 inflammatory axis. Nature 556, 501–504 (2018). source
Not checked in the free run.
May combine two claims.
PremisecitationDI selectively inhibits LPS-induced IL-6 while TNF-α levels remain unaffected.
“DI is reported to selectively inhibit LPS-induced IL-6 while TNF-α levels remain unaffected”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
May combine two claims.
Premisecitation4-OI is protective in an LPS lethality model in vivo, prolonging survival, improving body temperature regulation and decreasing pro-inflammatory cytokine production.
“4-OI was also shown to be protective in an LPS lethality model in vivo, prolonging survival, improving body temperature regulation and decreasing pro-inflammatory cytokine production59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningElevated fumarate levels may act as an endogenous anti-inflammatory signal to limit inflammation.
“Intriguingly, endogenous fumarate was also found to succinate GAPDH in both mouse and human macrophages, suggesting that elevated fumarate levels may act as an endogenous anti-inflammatory signal to limit inflammation, however, the precise role of fumarate accumulation remains an open question to be explored.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationFumarate accumulation inhibits the KDM5 family of histone demethylases, increasing H3K4me3 at the promoters of Tnf and Il6.
“The authors proposed that fumarate accumulation acted to inhibit the KDM5 family of histone demethylases, which subsequently increased the levels of H3K4me3, a marker of active gene transcription, at the promoters of both Tnf and Il6, thus providing the first link between Krebs cycle rewiring and epigenetic regulation in an inflammatory context97.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
Not checked in the free run.
May combine two claims.
PremisecitationFumarate binds glutathione, forming succinic-glutathione, and depletes this antioxidant molecule leading to unscheduled oxidative stress.
“Later, it was also shown that fumarate binds glutathione (forming succinic-glutathione (succinicGSH)), and thereby depletes this antioxidant molecule leading to unscheduled oxidative stress83,84.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [83] Shi, H. Z., Wang, D., Sun, X. N. & Sheng, L. MicroRNA-378 acts as a prognosis marker and inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting IRG1. Eur. Rev. Med. Pharmacol. Sci. 22, 3837–3846 (2018).
Not checked in the free run.
- cites [84] Pan, J. et al. Immune responsive gene 1, a novel oncogene, increases the growth and tumorigenicity of glioma. Oncol. Rep. 32, 1957–1966 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationIncreased IRG1 in glioma is associated with a decrease in miR-378, which targets Irg1, and poorer overall survival and clinicopathological parameters.
“This was associated with a decrease in the microRNA miR-378, which targets Irg1 as well as poorer overall survival and clinicopathological parameters.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
Not checked in the free run.
May combine two claims.
PremisecitationHLRCC is characterised by benign tumours of smooth muscle of skin and uterus and a very aggressive form of renal cancer.
“However, in 2002 it was shown that mutations of FH are the cause of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), a cancer predisposition syndrome characterised by benign tumours of the smooth muscle of skin and uterus, and a very aggressive form of renal cancer78.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] Cheon, Y. P., Xu, X., Bagchi, M. K. & Bagchi, I. C. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology 144, 5623–5630 (2003). source
Not checked in the free run.
May combine two claims.
PremisecitationDMF and MMF modify and irreversibly inhibit GAPDH enzymatic activity and aerobic glycolysis in PBMCs from mice and MS patients treated with DMF.
“This suggestion arose from the observation that the cell-permeable fumaric esters, DMF and MMF, modify and irreversibly inhibit GAPDH enzymatic activity and aerobic glycolysis in peripheral blood mononuclear cells (PBMCs) from mice and MS patients treated with DMF99.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
Not checked in the free run.
May combine two claims.
InterpretationcitationThere are two mechanisms for itaconate-induced Nrf2 activation: directly via KEAP1 2,3-dicarboxypropylation and indirectly via ROS production.
“suggesting there are two mechanisms for itaconate-induced Nrf2 activation; directly via KEAP1 2,3-dicarboxypropylation and indirectly via ROS production (which would then modify KEAP1)75.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDMF blocks the association of PKCθ with CD28 and T cell activation.
“Mechanistically, DMF blocked the association of PKCθ with the costimulatory receptor CD28 and T cell activation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationThe argininosuccinate shunt accounts for elevated fumarate levels observed in macrophages.
“As Asl cleaves argininosuccinate into arginine and fumarate, the authors proposed that this metabolic pathway accounted for the elevated fumarate levels observed in macrophages1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
Not checked in the free run.
May combine two claims.
PremisecitationDMF but not MMF inhibits activation of human and mouse T cells.
“Blewett and colleagues (2016) demonstrated that dimethyl fumarate (DMF), a potent electrophile which is currently used to treat psoriasis and relapse-remitting MS, but not MMF inhibited the activation of human and mouse T cells 49.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationElevated fumarate levels negatively regulate glycolysis via succination of the active site cysteine residue C152 in GAPDH.
“More recently, Kornberg and colleagues (2018) suggested that a potential consequence of elevated fumarate levels is to negatively regulate glycolysis via succination of the active site cysteine residue (C152) in GAPDH99,100.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
Not checked in the free run.
- cites [100] Adam, J. et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20, 524–537 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationIRG1 is essential for OXPHOS-driven mtROS production and bactericidal killing in zebrafish macrophages.
“The effect of itaconate on ROS production is consistent with a previous study in zebrafish macrophages, which demonstrated that IRG1 was essential for OXPHOS-driven mtROS production and bactericidal killing172.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [172] Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell. Metab. 20, 306–319 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationOverexpression of miR-378 suppresses glioma tumour growth in vitro and in vivo, EMT and metastasis.
“Overexpression of miR-378 suppressed glioma tumour growth both in vitro and in vivo, the epithelial-mesenchymal transition (EMT) and metastasis75.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
Not checked in the free run.
May combine two claims.
PremisecitationFumarate acts as a powerful inhibitor of the TET family of DNA demethylases and of a series of histone demethylases.
“Recent data demonstrated that fumarate acts as a powerful inhibitor of the TET family of DNA demethylases and of a series of histone demethylases91,92.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [91] Angiari, S. & O’Neill, L. A. Dimethyl fumarate: targeting glycolysis to treat MS. Cell Res. 28, 613–615 (2018). source
Not checked in the free run.
- cites [92] Kornberg, M. D. et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360, 449–453 (2018). source
Not checked in the free run.
May combine two claims.
PremisecitationInhibition of GOT1 by AOAA decreases D-2-HG levels and promotes Foxp3 expression and differentiation of TH17 cells to iTregs.
“Inhibition of GOT1 by aminooxyacetic acid (AOAA), which decreases D-2-HG levels, promoted expression Foxp3 and the differentiation of TH17 cells to iTregs143.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationGermline mutations in L2HGDH and D2HGDH cause L-2-hydroxyglutaric aciduria and D-2-hydroxyglutaric aciduria.
“The cause of these so-called 2-hydroxyglutaric acidurias (2HGAs) was attributed to germline mutations in L-2-HG dehydrogenase (L2HGDH) and D-2-HG dehydrogenase (D2HGDH), the mitochondrial enzymes responsible for the conversion of 2-HG to α-KG and thus its breakdown107-109.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [107] Bardella, C. et al. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. J. Pathol. 225, 4–11 (2011). source
Not checked in the free run.
- cites [108] Laukka, T. et al. Fumarate and succinate regulate expression of hypoxia-inducible genes via TET enzymes. J. Biol. Chem. 291, 4256–4265 (2016). source
Not checked in the free run.
- cites [109] Salminen, A., Kauppinen, A. & Kaarniranta, K. 2-Oxoglutarate-dependent dioxygenases are sensors of energy metabolism, oxygen availability, and iron homeostasis: potential role in the regulation of aging process. Cell. Mol. Life Sci. 72, 3897–3914 (2015). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningFumarate accumulation promotes genomic alterations that could give rise to cancer formation in HLRCC patients, cooperating with other oncogenic signals.
“Overall, these lines of evidence provide a potential model for how fumarate accumulation promotes genomic alterations that could give rise to cancer formation in HLRCC patients, cooperating with the other above-described oncogenic signals it elicits.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCD8+ T cells are highly dependent on activation of HIF-1α and glycolysis, which mediates trafficking into hypoxic tumour environments and inflamed tissue.
“Like TH17 cells, CD8+ T cells are highly dependent on the activation of HIF-1α and glycolysis, which is responsible for mediating trafficking into hypoxic tumour environments and inflamed tissue147,148.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [147] Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479–483 (2012). source
Not checked in the free run.
- cites [148] Wang, P. et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32, 3091–3100 (2013). source
Not checked in the free run.
May combine two claims.
PremisecitationNuclear FH generates fumarate via its reverse activity, which inhibits KDM2B and facilitates binding of DNA repair proteins.
“Here, via its reverse activity, it generates fumarate that inhibits histone lysine demethylase KDM2B, which in turn facilitates the binding of proteins involved in DNA repair177.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [177] Valls-Lacalle, L. et al. Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size. Sci. Rep. 8, 2442 (2018). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn D2HGA, about 50% of patients present with D2HGDH mutations, while the remaining half possess mutations in IDH2.
“In the case of D2HGA, about 50% of patients present with D2HGDH mutations, while the remaining half possess mutations in the Krebs cycle enzyme isocitrate dehydrogenase 2 (IDH2), which converts isocitrate to α-KG110.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [110] Isaacs, J. S. et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell. 8, 143–153 (2005). source
Not checked in the free run.
May combine two claims.
PremisecitationTH17 cells rely heavily on a switch from OXPHOS to glycolysis, requiring activation of HIF-1α and induction of RORγt.
“T-helper 17 (TH17) cells, derived from naïve CD4+ T cells, are one such subset that rely heavily on a switch from OXPHOS to glycolysis, a process that requires the activation of HIF-1α and induction of RORγt143,146.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
Not checked in the free run.
- cites [146] Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 17, 510–522 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationCDKN2A (P16) is hypermethylated and suppressed in tumours of HLRCC patients.
“Consistent with an important role of senescence bypass for the development of tumorigenesis, recent data in HLRCC patients showed that CDKN2A (also known as P16), a key player in senescence, is hypermethylated and suppressed in tumours85.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Frezza, C. Mitochondrial metabolites: undercover signalling molecules. Interface Focus 7, 20160100 (2017). source
Not checked in the free run.
May combine two claims.
PremisecitationElevated D-2-HG is associated with increased DNA methylation at the Foxp3 locus, resulting in its repression.
“The elevated levels of D-2-HG was associated with increased DNA methylation levels at the Foxp3 locus, the master transcription factor driving iTreg differentiation, resulting in its repression143.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationTH17 cell differentiation can be initiated by exogenous addition of D-2-HG to naïve CD4+ T cells or by genetic silencing of TET1 and TET2.
“Furthermore, TH17 cell differentiation could be initiated by exogenous addition of D-2-HG to naïve CD4+ T cells or by genetic silencing of TET1 and TET2, established targets of 2-HG143-145.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
Not checked in the free run.
- cites [144] Chowdhury, R. et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12, 463 (2011). source
Not checked in the free run.
- cites [145] Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 19, 17–30 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationUpon DNA damage, FH localises in the nucleus where it is phosphorylated by DNA-PKcs.
“Upon DNA damage, FH localises in the nucleus, where it is phosphorylated by the catalytic subunit of DNA-PK (DNA-PKcs)177.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [177] Valls-Lacalle, L. et al. Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size. Sci. Rep. 8, 2442 (2018). source
Not checked in the free run.
May combine two claims.
PremisecitationAberrant accumulation of fumarate in HLRCC correlates with increased endogenous damage, lower DNA repair efficiency and increased sensitivity to PARP inhibitors.
“In support of this unexpected function of fumarate, it was recently shown that the aberrant accumulation of this metabolite in HLRCC correlates with increased endogenous damage, lower DNA repair efficiency and increased sensitivity to poly-ADP ribose polymerase (PARP) inhibitors178.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [178] Kohlhauer, M. et al. Metabolomic profiling in acute ST-segment-elevation myocardial infarction identifies succinate as an early marker of human ischemia-reperfusion injury. J. Am. Heart Assoc. 7, e007546 (2018). source
Not checked in the free run.
May combine two claims.
PremisecitationD-2-HG inhibits FIH and PHD2 with IC50 values of 1.5 and 7.3 mM, respectively.
“Although the IC50 of D-2-HG toward KDM family members is in the low micromolar range (24-106 μM), it can also inhibit FIH and PHD2, with IC50 values of 1.5 and 7.3 mM, respectively121.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
Not checked in the free run.
May combine two claims.
PremisecitationHIF-1α stabilisation induces LDHA expression and activity, which converts glutamine-derived α-KG to L-2-HG.
“Mechanistically, HIF-1α stabilisation induced LDHA expression and activity, which promiscuously converted glutamine-derived α-KG to L-2-HG149.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
Not checked in the free run.
May combine two claims.
PremisecitationD-2-HG occupies the active site of histone demethylases, increasing histone methylation in primary gliomas.
“D-2-HG produced by mIDH1/2 has been shown to drive a CpG island methylator phenotype (G-CIMP) in both glioma and ICC tumours to promote tumorigenesis, and has also been found to occupy the active site of histone demethylases thereby increasing histone methylation in primary gliomas121,123-125.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
Not checked in the free run.
- cites [123] Rzem, R. et al. A gene encoding a putative FAD-dependent l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc. Natl. Acad. Sci. USA 101, 16849–16854 (2004). source
Not checked in the free run.
- cites [124] Struys, E. A. et al. Mutations in the d-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 76, 358–360 (2005). source
Not checked in the free run.
- cites [125] Topçu, M. et al. l-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum. Mol. Genet. 13, 2803–2811 (2004). source
Not checked in the free run.
May combine two claims.
PremisecitationL-2HG production under hypoxia is independent of IDH1 and 2 and primarily mediated by LDHA and MDH via promiscuous reduction of αKG, enhanced by acidic pH.
“The authors demonstrate that this is independent of IDH1 and 2 and primarily mediated by LDHA and malate dehydrogenase (MDH) via “promiscuous” reduction of αKG and this is enhanced by acidic pH52.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Wang, Y. et al. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. Nature 552, 273–277 (2017). source
Not checked in the free run.
May combine two claims.
PremisecitationD-2-HG-induced metabolic rewiring decreases NAAG, and NAAG levels are significantly lower in IDH-mutant human glioma tissue.
“This metabolic rewiring resulted in a decrease in a common dipeptide found in the brain N-acetyl-aspartyl-glutamate (NAAG), and NAAG levels were found to be significantly lower in IDH-mutant human glioma tissue134.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [134] Figueroa, M. E. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 18, 553–567 (2010). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningmIDH-derived D-2-HG accumulation is directly linked to DNA damage, genetic instability and carcinogenesis.
“As such, these findings directly link mIDH-derived D-2-HG accumulation to DNA damage, genetic instability and carcinogenesis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationD-2-HG accumulation in IDH-mutant glioma inhibits PHD hydroxylase and stabilises HIF-1α.
“Indeed, D-2-HG accumulation in IDH-mutant glioma has been found to inhibit PHD hydroxylase and stabilise HIF-1α126 and HIF-1αstabilisation has been shown to occur in IDH1-mutant brain tissue127.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [126] Kranendijk, M. et al. IDH2 mutations in patients with d-2-hydroxyglutaric aciduria. Science 330, 336 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationSomatic mutations in IDH1 and IDH2 are among the first genetic events in tumorigenesis in human glioma and AML and initiate pathogenesis by a common mechanism.
“Genomic studies have established that somatic mutations in IDH1 and IDH2 are perhaps the first genetic events to occur during tumorigenesis in human glioma and AML, and appear to initiate pathogenesis by a common mechanism103,115-117.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [103] Linehan, W. M. et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374, 135–145 (2016). source
Not checked in the free run.
- cites [115] Yogev, O. et al. Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol. 8, e1000328 (2010). source
Not checked in the free run.
- cites [116] Jiang, Y. et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nat. Cell Biol. 17, 1158–1168 (2015). source
Not checked in the free run.
- cites [117] Sulkowski, P. L. et al. Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair. Nat. Genet. 50, 1086–1092 (2018). source
Not checked in the free run.
May combine two claims.
PremisecitationUnder acidic conditions, αKG is protonated, promoting binding to LDHA and L-2HG production.
“Under acidic conditions αKG is protonated and this promotes binding to LDHA and L-2HG production.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Wang, Y. et al. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. Nature 552, 273–277 (2017). source
Not checked in the free run.
May combine two claims.
PremisecitationIDH-mutant cells display reduced DNA repair kinetics, accumulate DNA double stranded breaks, and are sensitized to alkylating agents.
“Indeed, IDH-mutant cells display reduced DNA repair kinetics, accumulate DNA double stranded breaks (DSBs) and are sensitized to alkylating agents131,174.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [131] MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259–283 (2013). source
Not checked in the free run.
- cites [174] Mi, W. et al. YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer. Nat. Commun. 8, 1088 (2017). source
Not checked in the free run.
May combine two claims.
InterpretationcitationD-2-HG accumulation under pathogenic conditions may contribute to tumorigenicity by stabilizing HIF-1α and impairing collagen biogenesis.
“the concentrations at which it accumulates under pathogenic conditions suggests HIF-1α stabilisation and impaired collagen biogenesis may contribute to tumorigenicity126-130.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [126] Kranendijk, M. et al. IDH2 mutations in patients with d-2-hydroxyglutaric aciduria. Science 330, 336 (2010). source
Not checked in the free run.
- cites [127] Nota, B. et al. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined d-2- and l-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 92, 627–631 (2013). source
Not checked in the free run.
- cites [128] Dang, L. & Su, S. M. Isocitrate dehydrogenase mutation and R-2-hydroxyglutarate: from basic discovery to therapeutics development. Annu. Rev. Biochem. 86, 305–331 (2017). source
Not checked in the free run.
- cites [129] Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009). source
Not checked in the free run.
- cites [130] Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008). source
Not checked in the free run.
May combine two claims.
PremisecitationThe increase in L-2-HG in CD8+ T cells occurs under normoxic conditions and is dependent on HIF-1α stabilisation.
“This increase occurred under normoxic conditions and was dependent on HIF-1α stabilisation149.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
Not checked in the free run.
May combine two claims.
PremisecitationL-2HG is sufficient to alter histone methylation, in particular H3K9me3, and can promote HIF-1α stabilization in normoxia.
“Functionally, L-2HG is both sufficient to try histone methylation, in particular histone 3 lysine 9 (H3K9me3), and can also promote HIF-1α stabilization in normoxia and therefore may assist with hypoxic adaptation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Du, J. et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806–809 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationAlmost all IDH1/2 mutations occur in a few unique locations in the active site, resulting in neomorphic activity converting α-KG to D-2-HG.
“Remarkably, almost all IDH1/2 mutations occur in a few unique locations in the active site of the enzymes, which results in the acquirement of a neomorphic enzymatic activity converting α-KG to the oncometabolite D-2-HG118-120.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [118] Johnson, T. I., Costa, A. S. H., Ferguson, A. N. & Frezza, C. Fumarate hydratase loss promotes mitotic entry in the presence of DNA damage after ionising radiation. Cell Death Dis. 9, 913 (2018). source
Not checked in the free run.
- cites [119] Ye, D., Guan, K. L. & Xiong, Y. Metabolism, activity, and targeting of d- and l-2-Hydroxyglutarates. Trends Cancer 4, 151–165 (2018). source
Not checked in the free run.
- cites [120] Chalmers, R. A. et al. d-2-hydroxyglutaric aciduria: case report and biochemical studies. J. Inherit. Metab. Dis. 3, 11–15 (1980). source
Not checked in the free run.
May combine two claims.
PremisecitationACLY is required to enhance histone acetylation levels and induce expression of cell cycle regulating genes in response to IL-2.
“The authors demonstrate that ACLY is required to enhance histone acetylation levels and induce the expression of cell cycle regulating genes in response to IL-2.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] Meiser, J. et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J. Biol. Chem. 291, 3932–3946 (2016). source
Not checked in the free run.
May combine two claims.
PremisecitationCitrate acts as a source of acetyl-CoA to drive histone acetylation, with impacts on tumor and immune cell function.
“Citrate, a component of the TCA cycle has been shown to act as a source of acetyl-CoA to drive histone acetylation and this process can have profound impacts on both tumor and immune cell function.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Gibson, G. E. et al. α-ketoglutarate dehydrogenase complex–dependent succinylation of proteins in neurons and neuronal cell lines. J. Neurochem. 134, 86–96 (2015). source
Not checked in the free run.
May combine two claims.
PremisecitationD-2-HG binds DNA methyltransferase DNMT1, which represses RIP3.
“D-2-HG has also been found to bind the DNA methyltransferase DNMT1, which subsequently represses receptor-interacting protein kinase 3 (RIP3).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [140] Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149–1153 (2009). source
Not checked in the free run.
- cites [141] Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationLDHA-deficient T cells show decreased acetyl-CoA levels and decreased H3K9Ac on the Ifng promoter.
“Mechanistically LDHA-deficient T cells showed decreased acetyl-CoA levels and decreased histone H3 acetylation at the lysine 9 residue (H3K9Ac), a histone mark associated with active transcription, on the Ifng promoter.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
Not checked in the free run.
May combine two claims.
PremisecitationACL is required for response to growth factor stimulation and during differentiation, including differentiation of murine 3T3-L1 pre-adipocytes into adipocytes.
“One of the earliest studies to identify a role for ACL in histone acetylation demonstrated a requirement for this gene in response to growth factor stimulation and during differentiation, for example the differentiation of murine 3T3- L1 pre-adipocytes into adipocytes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
Not checked in the free run.
May combine two claims.
PremisecitationD-2-HG impairs necroptosis and the small GTPase Cdc42, leading to suppression of MLK3-mediated apoptosis.
“Finally, D-2HG also impairs necroptosis and the small GTPase Cdc42, leading to suppression of mixed lineage kinase 3 (MLK3)-mediated apoptosis140,141.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [140] Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149–1153 (2009). source
Not checked in the free run.
- cites [141] Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationArtificial acetyl-CoA reduction through ACLY inhibition decreases IFN-γ expression, and acetate supplementation corrects H3K9Ac marks and IFN-γ expression in LDHA-deficient T cells.
“Furthermore, artificial acetyl-CoA reduction, through inhibition of ACLY, decreased IFN-γ expression and acetate supplementation, which augmented acetyl-CoA production, corrected H3K9Ac marks and IFN-γ expression in LDHA-deficient T cells.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
Not checked in the free run.
May combine two claims.
PremisecitationHistone acetylation in mammalian cells is dependent on ACL, and ACL silencing decreases histone acetylation.
“It has been demonstrated in mammalian cells that histone acetylation is dependent on ACL, the enzyme that converts citrate into acetyl-CoA, a required co-factor for acetylation,54 with ACL silencing decreasing the degree of histone acetylation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
Not checked in the free run.
May combine two claims.
PremisecitationACLY deficiency results in impaired BRCA1 recruitment to DSBs and suppression of homologous recombination.
“ACLY deficiency results in impaired BRCA1 recruitment to sites of DSBs and suppression of homologous recombination.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationACLY is phosphorylated downstream of AKT activation following DNA damage and facilitates histone acetylation at DSB sites, enabling BRCA1 recruitment and DNA repair by homologous recombination.
“ACLY is phosphorylated downstream of AKT activation, following DNA damage and this facilitates histone acetylation at double strand break (DSB) sites, enabling breast cancer early onset 1 (BRCA1) recruitment and DNA repair by homologous recombination.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationSuccinate production is enhanced during inflammation, acting as a signal from mitochondria to cytosol to activate pro-inflammatory gene expression and generating ROS as a pro-inflammatory redox signal.
“The production of succinate is also enhanced during inflammation13, acting as a signal from mitochondria to the cytosol to activate pro-inflammatory gene expression while also generating ROS as a further pro-inflammatory redox signal28.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
Not checked in the free run.
- cites [28] Rasola, A., Neckers, L. & Picard, D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 24, 455–463 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationMice with T cell-specific LDHA deficiency produce less IFN-γ and are protected from immunopathology.
“Mice with an T cell-specific LDHA deficiency produced less IFN-γ and were protected from immunopathology.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
Not checked in the free run.
May combine two claims.
PremisecitationD-2-HG is a competitive inhibitor of SDH, resulting in succinate accumulation, impaired mitochondrial oxygen consumption, and increased protein succinylation.
“D-2-HG has also been found to be a competitive inhibitor of SDH, a key metabolic enzyme and tumour suppressor as previously discussed, resulting in the accumulation of succinate, impaired mitochondrial oxygen consumption and increased protein succinylation139.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [139] Suzuki, H. et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat. Genet. 47, 458–468 (2015). source
Not checked in the free run.
May combine two claims.
PremisecitationD-2-HG activates NF-κB in bone marrow stromal cells in an IκB kinase-independent fashion, generating a stromal niche for IDH mutant AML development.
“D-2-HG activates NF-κB in bone marrow stromal cells in an IκB kinase-independent fashion, thus generating a stromal niche for IDH mutant AML development138.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [138] Finlay, D. K. et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441–2453 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationHigh levels of succinate or 2-HG inhibit α-KGDDs, including PHDs, TET DNA demethylases, and JMJDs.
“High levels of succinate or 2-HG inhibit α-KGDDs. These include the PHDs, the TET DNA demethylases, and the JMJDs154-156”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
Not checked in the free run.
- cites [61] Shin, J. H. et al. 1H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J. Proteome Res. 10, 2238–2247 (2011). source
Not checked in the free run.
- cites [62] Sugimoto, M. S. H. Y. et al. Non-targeted metabolite profiling in activated macrophage secretion. Metabolomics 8, 624–633 (2011). source
Not checked in the free run.
- cites [154] Sasaki, M. et al. d-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. Genes Dev. 26, 2038–2049 (2012). source
Not checked in the free run.
- cites [155] Tarhonskaya, H. et al. Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases. Nat. Commun. 5, 3423 (2014). source
Not checked in the free run.
- cites [156] Wang, P. et al. Oncometabolite d-2-hydroxyglutarate inhibits ALKBH DNA repair enzymes and sensitizes IDH mutant cells to alkylating agents. Cell Rep. 13, 2353–2361 (2015). source
Not checked in the free run.
May combine two claims.
PremisecitationInhibitors of α-KGDDs are often non-specific, hitting multiple isoforms or α-KGDD family members, such as DMOG acting on TETs but also PHDs.
“Inhibitors of α-KGDDs are often non-specific, either hitting multiple isoforms or a-KGDD family members, such as dimethyloxaloylglycine (DMOG) acting on TETs but also PHDs [7].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Nadjsombati, M. S. et al. Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit. Immunity 49, 33–41.e7 (2018). source
Not checked in the free run.
May combine two claims.
PremisecitationSpecific PHD inhibitors such as Vadadustat have shown promise in chronic kidney disease, increasing erythropoiesis and providing a means of attenuating HIF in other pathologies.
“However, specific PHD inhibitors have been developed, such as Vadadustat, and have shown promise in chronic kidney disease, increasing erythropoiesis and providing a means of attenuating HIF in other pathologies [10].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationEnasidenib binds the mutated but not wild-type form of IDH2 to prevent D-2-HG production.
“a drug Enasidenib has been developed for AML, which binds to the mutated, but not the wild-type, form of IDH2 only to prevent D-2-HG production163.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [163] Chen, J. Y. et al. The oncometabolite R-2-hydroxyglutarate activates NF-κB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells. Sci. Rep. 6, 1 (2016). source
Not checked in the free run.
Classified as probably not a substantial claim.
Interpretationnone givenLimited human and in vivo data exist on metabolite signalling.
“One critical point to consider is the limited human and in vivo data existing to date.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenStudies in human immune cells are currently very limited.
“Studies in human immune cells are also currently very limited.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningSuccinate promotes a potentially tumour-fighting, pro-inflammatory state but also drives HIF-1α activation in tumours associated with cancer progression.
“succinate, which promotes a potentially tumour-fighting, pro-inflammatory state also drives HIF-1α activation in tumours which is associated with cancer progression.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation4-OI is an itaconate mimic that is protective in a mouse model of sepsis, decreasing cytokine production and increasing survival.
“4-OI is an itaconate mimic that was protective in a mouse model of sepsis, decreasing cytokine production and increasing survival59.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
Not checked in the free run.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The nervous system coordinates whole-body metabolism by producing neurohormones that act locally and by direct innervation of target tissues.
“Alternatively, the nervous system coordinates whole‐body metabolism not only by the production of neurohormones that act locally, but also by direct innervation of the target tissues 2, 3, 4, 5.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The fifth Krebs-cycle step is assigned to the wrong enzyme
MinorThe paper describes OGDH as catalysing the fourth step and succinyl-CoA synthetase as producing GTP or ATP in the following step. It then attributes that fifth, substrate-level phosphorylation step to OGDH.
“As such, the reaction catalysed by OGDH is referred to as substrate level phosphorylation and constitutes the fifth step in the Krebs cycle.”
“In the fourth step, OGDH catalyses the oxidative decarboxylation of α-KG to form succinyl-CoA, NADH and CO2. Succinyl-CoA synthetase then catalyses the hydrolysis of succinyl-CoA, coupled to the condensation of GDP and inorganic phosphate (Pi), or ADP and Pi, to form succinate and either GTP or ATP.”
Citation 75 does not identify the stated Weiss study
MinorThe statement attributes an itaconate-ROS-Nrf2 finding to Weiss and colleagues and cites reference 75. Reference 75 instead lists Shi and colleagues' glioma microRNA study; the listed Weiss study is reference 74.
“Furthermore, Weiss and colleagues (2018) demonstrated that ROS production in response to itaconate regulates Nrf2, suggesting there are two mechanisms for itaconate-induced Nrf2 activation; directly via KEAP1 2,3-dicarboxypropylation and indirectly via ROS production (which would then modify KEAP1)75.”
“75. Shi H Wang D Sun X S L MicroRNA-378 acts as a prognosis marker and inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting IRG1 Eur Rev Med Pharmacol Sci 2018 6 22 12 3837 3846 10.26355/eurrev_201806_15268 2018 29949160”
PHD inhibition is described as attenuating HIF
MinorThe paper says PHD activity marks HIF-1α for degradation. Inhibiting PHDs would therefore oppose, rather than provide, that mechanism for attenuating HIF.
“However, specific PHD inhibitors have been developed, such as Vadadustat, and have shown promise in chronic kidney disease, increasing erythropoiesis and providing a means of attenuating HIF in other pathologies [10].”
“In the presence of oxygen, conserved proline residues in the HIF-1α subunit are hydroxylated by PHD 1, 2 and 3 16. Hydroxylation provides a recognition site for the binding of Von Hippel-Lindau (VHL) E3 ubiquitin ligase, which ubiquitinates HIF-1α and subsequently targets it for proteasomal degradation17.”
Cites
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Cappello, V., Marchetti, L., Parlanti, P., Landi, S., Tonazzini, I., Cecchini, M., Piazza, V., & Gemmi, M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0001-8 · Cited by 13,097 · see citing works
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · see citing works
Self-citationAn Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works
<i>IDH1</i> and <i>IDH2</i> Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847 · see citing works
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · see citing works
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,834 · see citing works
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176 · see citing works
Self-citationCancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154 · see citing works
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333 · see citing works
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148 · see citing works
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Chouchani, E. T., Pell, V. R., Gaude, E., Aksentijević, D., Sundier, S. Y., Robb, E. L., Logan, A., Nadtochiy, S. M., Ord, E. N. J., Smith, A. C., et al. (2014) · Nature · doi:10.1038/nature13909 · Cited by 2,907 · see citing works
Self-citationXu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766 · see citing works
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617 · see citing works
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337 · see citing works
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298 · see citing works
Mills, E. L., Kelly, B., Logan, A., Costa, A. S. H., Varma, M., Bryant, C. E., Tourlomousis, P., Däbritz, J. H. M., Gottlieb, E., Latorre, I., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.064 · Cited by 2,291 · see citing works
Self-citationmTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
Cheng, S.-C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., et al. (2014) · Science · doi:10.1126/science.1250684 · Cited by 2,224 · see citing works
Self-citationRecurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219 · see citing works
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204 · see citing works
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · see citing works
Jha, A. K., Huang, S. C.-C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K. M., Ashall, J., Everts, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.005 · Cited by 2,066 · see citing works
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020 · see citing works
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974 · see citing works
Brabletz, T., Kalluri, R., Nieto, M. A., & Weinberg, R. A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.118 · Cited by 1,961 · see citing works
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Mills, E. L., Ryan, D. G., Prag, H. A., Dikovskaya, D., Menon, D., Zaslona, Z., Jedrychowski, M. P., Costa, A. S. H., Higgins, M., Hams, E., et al. (2018) · Nature · doi:10.1038/nature25986 · Cited by 1,885 · see citing works
Self-citationNrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11624 · Cited by 1,878 · see citing works
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
Saeed, S., Quintin, J., Kerstens, H. H. D., Rao, N. A., Aghajanirefah, A., Matarese, F., Cheng, S.-C., Ratter, J., Berentsen, K., van der Ent, M. A., et al. (2014) · Science · doi:10.1126/science.1251086 · Cited by 1,761 · see citing works
Metabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692 · see citing works
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635 · see citing works
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595 · see citing works
Lampropoulou, V., Sergushichev, A., Bambousková, M., Nair, S., Vincent, E. E., Loginicheva, E., Cervantes‐Barragán, L., Ma, X., Huang, S. C., Griss, T., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.004 · Cited by 1,547 · see citing works
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., et al. (2011) · Science · doi:10.1126/science.1207861 · Cited by 1,429 · see citing works
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336 · see citing works
Insulator dysfunction and oncogene activation in IDH mutant gliomas
Flavahan, W. A., Drier, Y., Liau, B. B., Gillespie, S. M., Venteicher, A. S., Stemmer-Rachamimov, A. O., Suvà, M. L., & Bernstein, B. E. (2016) · Nature · doi:10.1038/nature16490 · Cited by 1,288 · see citing works
Metabolic Regulation of T Lymphocytes
MacIver, N. J., Michalek, R. D., & Rathmell, J. C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095956 · Cited by 1,244 · see citing works
Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production
Michelucci, A., Cordes, T., Ghelfi, J., Pailot, A., Reiling, N., Goldmann, O., Binz, T., Wegner, A., Tallam, A., Rausell, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218599110 · Cited by 1,191 · see citing works
Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., et al. (2012) · Genes & Development · doi:10.1101/gad.191056.112 · Cited by 1,188 · see citing works
Metabolic heterogeneity in human lung tumors
Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.034 · Cited by 1,138 · see citing works
Glioma-Derived Mutations in <i>IDH1</i> Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119 · see citing works
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Chowdhury, R., Yeoh, K. K., Tian, Y., Hillringhaus, L., Bagg, E. A., Rose, N. R., Leung, I. K. H., Li, X. S., Woon, E. C. Y., Yang, M., et al. (2011) · The EMBO Reports · doi:10.1038/embor.2011.43 · Cited by 1,035 · see citing works
Identification of lysine succinylation as a new post-translational modification
Zhang, Z., Tan, M., Xie, Z., Dai, L., Chen, Y., & Zhao, Y. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.495 · Cited by 1,027 · see citing works
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
Watanabe, T., Nobusawa, S., Kleihues, P., & Ohgaki, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080958 · Cited by 1,027 · see citing works
SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways
Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M. M., Skinner, M. E., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.001 · Cited by 1,000 · see citing works
Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958 · see citing works
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447-5454.1992 · Cited by 951 · see citing works
Arts, R. J. W., Novakovic, B., ter Horst, R., Carvalho, A., Bekkering, S., Lachmandas, E., Rodrigues, F., Silvestre, R., Cheng, S.-C., Wang, S.-Y., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.008 · Cited by 930 · see citing works
Self-citationRegulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (2009) · Physiology · doi:10.1152/physiol.00045.2008 · Cited by 926 · see citing works
Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors
He, W., Miao, F. J.-P., Lin, D. C.-H., Schwandner, R. T., Wang, Z., Gao, J., Chen, J.-L., Tian, H., & Ling, L. (2004) · Nature · doi:10.1038/nature02488 · Cited by 909 · cited 6× · see citing works
“mitochondrial enzymes CS (1), IDH (2), ACO2 (3), α -KG dehydrogenase”
BackgroundInfluentialMutational landscape and clonal architecture in grade II and III gliomas
Suzuki, H., Aoki, K., Chiba, K., Sato, Y., Shiozawa, Y., Shiraishi, Y., Shimamura, T., Niida, A., Motomura, K., Ohka, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3273 · Cited by 831 · see citing works
Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
Peng, M., Yin, N., Chhangawala, S., Xu, K., Leslie, C. S., & Li, M. O. (2016) · Science · doi:10.1126/science.aaf6284 · Cited by 787 · see citing works
A Unifying Mechanism for Mitochondrial Superoxide Production during Ischemia-Reperfusion Injury
Chouchani, E. T., Pell, V. R., James, A. M., Work, L. M., Saeb-Parsy, K., Frezza, C., Krieg, T., & Murphy, M. P. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.009 · Cited by 752 · see citing works
Self-citationElectrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis
Bambouskova, M., Gorvel, L., Lampropoulou, V., Sergushichev, A., Loginicheva, E., Johnson, K., Korenfeld, D., Mathyer, M. E., Kim, H., Huang, L.-H., et al. (2018) · Nature · doi:10.1038/s41586-018-0052-z · Cited by 713 · see citing works
Losman, J.-A., Looper, R. E., Koivunen, P., Lee, S., Schneider, R. K., McMahon, C., Cowley, G. S., Root, D. E., Ebert, B. L., & Kaelin, W. G. (2013) · Science · doi:10.1126/science.1231677 · Cited by 703 · see citing works
HIF-1α expression regulates the bactericidal capacity of phagocytes
Peyssonnaux, C., Datta, V., Cramer, T., Doedens, A. L., Theodorakis, E. A., Gallo, R. L., Hurtado‐Ziola, N., Nizet, V., & Johnson, R. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23865 · Cited by 702 · see citing works
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
Kornberg, M. D., Bhargava, P., Kim, P. M., Putluri, V., Snowman, A. M., Putluri, N., Calabresi, P. A., & Snyder, S. H. (2018) · Science · doi:10.1126/science.aan4665 · Cited by 687 · see citing works
Histone acetylation and deacetylation in yeast
Kurdistani, S. K., & Grunstein, M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1075 · Cited by 677 · see citing works
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen
Doedens, A. L., Phan, A. T., Stradner, M. H., Fujimoto, J. K., Nguyen, J. V., Yang, E., Johnson, R. S., & Goldrath, A. W. (2013) · Nature Immunology · doi:10.1038/ni.2714 · Cited by 660 · see citing works
Lysine succinylation and lysine malonylation in histones
Xie, Z., Dai, J., Dai, L., Tan, M., Cheng, Z., Wu, Y., Boeke, J. D., & Zhao, Y. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015875 · Cited by 613 · see citing works
Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112607 · Cited by 596 · see citing works
Adam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G. W., Wolhuter, K., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.006 · Cited by 585 · see citing works
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V. R., da Costa, A. S. H., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M. G. B., et al. (2016) · Nature · doi:10.1038/nature19353 · Cited by 584 · see citing works
Self-citationKAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase
Wang, Y., Guo, Y. R., Liu, K., Yin, Z., Liu, R., Xia, Y., Tan, L., Yang, P., Lee, J.-H., Li, X.-J., et al. (2017) · Nature · doi:10.1038/nature25003 · Cited by 567 · see citing works
Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation
Lee, J. V., Carrer, A., Shah, S., Snyder, N. W., Wei, S., Venneti, S., Worth, A. J., Yuan, Z.-F., Lim, H.-W., Liu, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.004 · Cited by 563 · see citing works
Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit
Nadjsombati, M. S., McGinty, J. W., Lyons-Cohen, M. R., Jaffe, J. B., DiPeso, L., Schneider, C., Miller, C. N., Pollack, J. L., Nagana Gowda, G. A., Fontana, M. F., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.016 · Cited by 556 · see citing works
Accumulation of succinate controls activation of adipose tissue thermogenesis
Mills, E. L., Pierce, K. A., Jedrychowski, M. P., Garrity, R., Winther, S., Vidoni, S., Yoneshiro, T., Spinelli, J. B., Lu, G. Z., Kazak, L., et al. (2018) · Nature · doi:10.1038/s41586-018-0353-2 · Cited by 539 · see citing works
Self-citationCordes, T., Wallace, M., Michelucci, A., Divakaruni, A. S., Sapcariu, S. C., Sousa, C., Koseki, H., Cabrales, P., Murphy, A. N., Hiller, K., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.685792 · Cited by 526 · see citing works
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity
Rubic, T., Lametschwandtner, G., Jost, S., Hinteregger, S., Kund, J., Carballido-Perrig, N., Schwärzler, C., Junt, T., Voshol, H., Meingassner, J. G., et al. (2008) · Nature Immunology · doi:10.1038/ni.1657 · Cited by 525 · see citing works
Littlewood-Evans, A. J., Sarret, S., Apfel, V., Loesle, P., Dawson, J., Zhang, J., Muller, A., Tigani, B., Kneuer, R., Patel, S., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160061 · Cited by 519 · see citing works
A small jab – a big effect: nonspecific immunomodulation by vaccines
Benn, C. S., Netea, M. G., Selin, L. K., & Aaby, P. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.004 · Cited by 517 · see citing works
Hypoxia Induces Production of L-2-Hydroxyglutarate
Intlekofer, A. M., Dematteo, R. G., Venneti, S., Finley, L. W. S., Lu, C., Judkins, A. R., Rustenburg, A. S., Grinaway, P. B., Chodera, J. D., Cross, J. R., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.023 · Cited by 513 · see citing works
Smith, R. A. J., Hartley, R. C., Cochemé, H. M., & Murphy, M. P. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.010 · Cited by 501 · see citing works
Self-citationPyruvate carboxylase is critical for non–small-cell lung cancer proliferation
Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci72873 · Cited by 497 · see citing works
Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus
Okabe, M., Lies, D., Kanamasa, S., & Park, E. Y. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2132-3 · Cited by 488 · see citing works
Peyssonnaux, C., Cejudo-Martin, P., Doedens, A., Zinkernagel, A. S., Johnson, R. S., & Nizet, V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7516 · Cited by 480 · see citing works
A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling
Schneider, C., O’Leary, C. E., von Moltke, J., Liang, H.-E., Ang, Q. Y., Turnbaugh, P. J., Radhakrishnan, S., Pellizzon, M., Ma, A., & Locksley, R. M. (2018) · Cell · doi:10.1016/j.cell.2018.05.014 · Cited by 478 · see citing works
Yen, K., Travins, J., Wang, F., David, M. D., Artin, E., Straley, K., Padyana, A., Gross, S., DeLaBarre, B., Tobin, E., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1034 · Cited by 471 · see citing works
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Reitman, Z. J., Jin, G., Karoly, E. D., Spasojevic, I., Yang, J., Kinzler, K. W., He, Y., Bigner, D. D., Vogelstein, B., & Yan, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019393108 · Cited by 449 · see citing works
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441 · see citing works
Fan, T. W. ‐., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H. T., Bousamra, M., & Miller, D. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-41 · Cited by 438 · see citing works
Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB
Frede, S., Stockmann, C., Freitag, P., & Fandrey, J. (2006) · Biochemical Journal · doi:10.1042/bj20051839 · Cited by 436 · see citing works
S-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate
Tyrakis, P. A., Palazon, A., Macias, D., Lee, K. L., Phan, A. T., Veliça, P., You, J., Chia, G. S., Sim, J., Doedens, A., et al. (2016) · Nature · doi:10.1038/nature20165 · Cited by 433 · see citing works
Metabolic signatures of exercise in human plasma
Lewis, G. D., Farrell, L., Wood, M. J., Martinovic, M., Arany, Z., Rowe, G. C., Souza, A., Cheng, S., McCabe, E. L., Yang, E., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001006 · Cited by 432 · see citing works
Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01338-07 · Cited by 427 · see citing works
Jantsch, J., Chakravortty, D., Turza, N., Prechtel, A. T., Buchholz, B., Gerlach, R. G., Volke, M., Gläsner, J., Warnecke, C., Wiesener, M. S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4697 · Cited by 414 · see citing works
Ooi, A., Wong, J.-C., Petillo, D., Roossien, D., Perrier-Trudova, V., Whitten, D., Min, B. W. H., Tan, M.-H., Zhang, Z., Yang, X. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.024 · Cited by 401 · see citing works
Wang, P., Dong, Q., Zhang, C., Kuan, P.-F., Liu, Y., Jeck, W. R., Andersen, J. B., Jiang, W., Savich, G. L., Tan, T.-X., et al. (2013) · Oncogene · doi:10.1038/onc.2012.315 · Cited by 399 · see citing works
Mitochondria-Targeted Small Molecule Therapeutics and Probes
Smith, R. A. J., Hartley, R. C., & Murphy, M. P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3969 · Cited by 399 · see citing works
Self-citationMetabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism
Xu, T., Stewart, K. M., Wang, X., Liu, K., Xie, M., Ryu, J. K., Li, K., Ma, T., Wang, H., Ni, L., et al. (2017) · Nature · doi:10.1038/nature23475 · Cited by 395 · see citing works
Metabolism of [U‐ <sup>13</sup> C]glucose in human brain tumors <i>in vivo</i>
Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2794 · Cited by 341 · see citing works
Wang, F., Wang, K., Xu, W., Zhao, S., Ye, D., Wang, Y., Xu, Y., Zhou, L., Chu, Y., Zhang, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.065 · Cited by 340 · see citing works
Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications
Yousif, L. F., Stewart, K. M., & Kelley, S. O. (2009) · ChemBioChem · doi:10.1002/cbic.200900185 · Cited by 330 · see citing works
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
Laukka, T., Mariani, C. J., Ihantola, T., Cao, J. Z., Hokkanen, J., Kaelin, W. G., Godley, L. A., & Koivunen, P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.688762 · Cited by 307 · see citing works
The Proto-oncometabolite Fumarate Binds Glutathione to Amplify ROS-Dependent Signaling
Sullivan, L. B., Martinez-Garcia, E., Nguyen, H., Mullen, A. R., Dufour, E., Sudarshan, S., Licht, J. D., Deberardinis, R. J., & Chandel, N. S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.003 · Cited by 304 · see citing works
Sasaki, M., Knobbe, C. B., Itsumi, M., Elia, A. J., Harris, I. S., Chio, I. I. C., Cairns, R. A., McCracken, S., Wakeham, A., Haight, J., et al. (2012) · Genes & Development · doi:10.1101/gad.198200.112 · Cited by 296 · see citing works
Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination
Sivanand, S., Rhoades, S., Jiang, Q., Lee, J. V., Benci, J., Zhang, J., Yuan, S., Viney, I., Zhao, S., Carrer, A., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.008 · Cited by 295 · see citing works
Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response
Saito, R., Suzuki, T., Hiramoto, K., Asami, S., Naganuma, E., Suda, H., Iso, T., Yamamoto, H., Morita, M., Baird, L., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00868-15 · Cited by 294 · see citing works
Progress in understanding 2‐hydroxyglutaric acidurias
Kranendijk, M., Struys, E. A., Salomons, G. S., Van der Knaap, M. S., & Jakobs, C. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9462-5 · Cited by 292 · see citing works
Peruzzotti-Jametti, L., Bernstock, J. D., Vicario, N., Costa, A. S. H., Kwok, C. K., Leonardi, T., Booty, L. M., Bicci, I., Balzarotti, B., Volpe, G., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.01.020 · Cited by 285 · see citing works
Self-citationJin, Z., Wei, W., Yang, M., Du, Y., & Wan, Y. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.011 · Cited by 283 · see citing works
Bardella, C., El‐Bahrawy, M., Frizzell, N., Adam, J., Ternette, N., Hatipoglu, E., Howarth, K., O'Flaherty, L., Roberts, I., Turner, G., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2932 · Cited by 281 · see citing works
Fumarate induces redox-dependent senescence by modifying glutathione metabolism
Zheng, L., Cardaci, S., Jerby, L., MacKenzie, E. D., Sciacovelli, M., Johnson, T. I., Gaude, E., King, A., Leach, J. D. G., Edrada-Ebel, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms7001 · Cited by 281 · see citing works
Self-citationGrassian, A. R., Parker, S. J., Davidson, S. M., Divakaruni, A. S., Green, C. R., Zhang, X., Slocum, K. L., Pu, M., Lin, F., Vickers, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0772-t · Cited by 280 · see citing works
Nair, S., Huynh, J. P., Lampropoulou, V., Loginicheva, E., Esaulova, E., Gounder, A. P., Boon, A. C. M., Schwarzkopf, E. A., Bradstreet, T. R., Edelson, B. T., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180118 · Cited by 280 · see citing works
Lei, W., Ren, W., Ohmoto, M., Urban, J. F., Matsumoto, I., Margolskee, R. F., & Jiang, P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720758115 · Cited by 279 · see citing works
L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH
Intlekofer, A. M., Wang, B., Liu, H., Shah, H., Carmona-Fontaine, C., Rustenburg, A. S., Salah, S., Gunner, M. R., Chodera, J. D., Cross, J. R., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2307 · Cited by 268 · see citing works
Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
Weiss, J. M., Davies, L. C., Karwan, M., Ileva, L., Ozaki, M. K., Cheng, R. Y. S., Ridnour, L. A., Annunziata, C. M., Wink, D. A., & McVicar, D. W. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99169 · Cited by 267 · see citing works
Hall, C. J., Boyle, R. H., Astin, J. W., Flores, M. V., Oehlers, S. H., Sanderson, L. E., Ellett, F., Lieschke, G. J., Crosier, K. E., & Crosier, P. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.018 · Cited by 266 · see citing works
Enzyme Inhibition in Relation to Chemotherapy.
Ackermann, W. W., & Potter, V. R. (1949) · Experimental Biology and Medicine · doi:10.3181/00379727-72-17313 · Cited by 262 · see citing works
Naujoks, J., Tabeling, C., Dill, B. D., Hoffmann, C., Brown, A. S., Kunze, M., Kempa, S., Peter, A., Mollenkopf, H.-J., Dorhoi, A., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005408 · Cited by 261 · see citing works
Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria
Jean, S. R., Ahmed, M., Lei, E. K., Wisnovsky, S., & Kelley, S. O. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00277 · Cited by 252 · see citing works
Shin, J.-H., Yang, J.-Y., Jeon, B.-Y., Yoon, Y. J., Cho, S.-N., Kang, Y.-H., Ryu, D. H., & Hwang, G.-S. (2011) · Journal of Proteome Research · doi:10.1021/pr101054m · Cited by 247 · see citing works
Li, F., He, X., Ye, D., Lin, Y., Yu, H., Yao, C., Huang, L., Zhang, J., Wang, F., Xu, S., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.017 · Cited by 244 · see citing works
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
Yeh, T., Leissing, T. M., Abboud, M. I., Thinnes, C. C., Atasoylu, O., Holt‐Martyn, J. P., Zhang, D., Tumber, A., Lippl, K., Lohans, C. T., et al. (2017) · Chemical Science · doi:10.1039/c7sc02103h · Cited by 244 · see citing works
Meiser, J., Krämer, L., Sapcariu, S. C., Battello, N., Ghelfi, J., D'Herouel, A. F., Skupin, A., & Hiller, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.676817 · Cited by 243 · see citing works
Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Ye, D., Guan, K.-L., & Xiong, Y. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2017.12.005 · Cited by 242 · see citing works
Pérgola, P. E., Spinowitz, B., Hartman, C., Maroni, B. J., & Haase, V. H. (2016) · Kidney International · doi:10.1016/j.kint.2016.07.019 · Cited by 239 · see citing works
L‐2‐Hydroxyglutaric aciduria: an inborn error of metabolism?
Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H., & Wadman, S. K. (1980) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02312543 · Cited by 226 · see citing works
Yogev, O., Yogev, O., Singer, E., Shaulian, E., Goldberg, M., Fox, T. D., & Pines, O. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000328 · Cited by 220 · see citing works
Itaconate, an isocitrate lyase-directed inhibitor in Pseudomonas indigofera
McFadden, B. A., & Purohit, S. (1977) · Journal of Bacteriology · doi:10.1128/jb.131.1.136-144.1977 · Cited by 220 · see citing works
Sulkowski, P. L., Sundaram, R. K., Oeck, S., Corso, C. D., Liu, Y., Noorbakhsh, S., Niger, M., Boeke, M., Ueno, D., Kalathil, A. N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0170-4 · Cited by 213 · see citing works
Ariza, A. C., Deen, P. M. T., & Robben, J. H. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00022 · Cited by 211 · see citing works
Lactate dehydrogenase A silencing in IDH mutant gliomas
Chesnelong, C., Chaumeil, M. M., Blough, M. D., Al-Najjar, M., Stechishin, O. D., Chan, J. A., Pieper, R. O., Ronen, S. M., Weiss, S., Luchman, H. A., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not243 · Cited by 210 · see citing works
Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation
Jiang, Y., Qian, X., Shen, J., Wang, Y., Li, X., Liu, R., Xia, Y., Chen, Q., Peng, G., Lin, S.-Y., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3209 · Cited by 208 · see citing works
Wang, P., Wu, J., Ma, S., Zhang, L., Yao, J., Hoadley, K. A., Wilkerson, M. D., Perou, C. M., Guan, K.-L., Ye, D., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.029 · Cited by 206 · see citing works
Dang, L., & Su, S.-S. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044732 · Cited by 204 · see citing works
Accumulation of Succinate in Cardiac Ischemia Primarily Occurs via Canonical Krebs Cycle Activity
Zhang, J., Wang, Y. T., Miller, J. H., Day, M. M., Munger, J. C., & Brookes, P. S. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.104 · Cited by 203 · see citing works
<i>IDH2</i> Mutations in Patients with <scp>d</scp> -2-Hydroxyglutaric Aciduria
Kranendijk, M., Struys, E. A., van Schaftingen, E., Gibson, K. M., Kanhai, W. A., van der Knaap, M. S., Amiel, J., Buist, N. R., Das, A. M., de Klerk, J. B., et al. (2010) · Science · doi:10.1126/science.1192632 · Cited by 195 · see citing works
Rzem, R., Veiga-da-Cunha, M., Noël, G., Goffette, S., Nassogne, M.-C., Tabarki, B., Schöller, C., Marquardt, T., Vikkula, M., & Van Schaftingen, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404840101 · Cited by 195 · see citing works
Inoue, S., Li, W. Y., Tseng, A., Beerman, I., Elia, A., Bendall, S. C., Lemonnier, F., Kron, K. J., Cescon, D. W., Hao, Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.018 · Cited by 194 · see citing works
Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells
Blewett, M. M., Xie, J., Zaro, B. W., Backus, K. M., Altman, A., Teijaro, J. R., & Cravatt, B. F. (2016) · Science Signaling · doi:10.1126/scisignal.aaf7694 · Cited by 194 · see citing works
Folbergrová, J., Ljunggren, B., Norberg, K. A., & Siesjö, B. K. (1974) · Brain Research · doi:10.1016/0006-8993(74)90690-8 · Cited by 192 · see citing works
The emerging role of fumarate as an oncometabolite
Yang, M., Soga, T., Pollard, P. J., & Adam, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00085 · Cited by 189 · see citing works
Brennan, M. S., Matos, M. F., Li, B., Hronowski, X., Gao, B., Juhasz, P., Rhodes, K. J., & Scannevin, R. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120254 · Cited by 188 · see citing works
SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes
van Diepen, J. A., Robben, J. H., Hooiveld, G. J., Carmone, C., Alsady, M., Boutens, L., Bekkenkamp-Grovenstein, M., Hijmans, A., Engelke, U. F. H., Wevers, R. A., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4261-z · Cited by 187 · see citing works
TET family dioxygenases and DNA demethylation in stem cells and cancers
An, J., Rao, A., & Ko, M. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.5 · Cited by 187 · see citing works
Mills, E., Ogrodnik, M., Plave, A., & Mao-Draayer, Y. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00005 · Cited by 187 · see citing works
Self-citationThe oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
Carbonneau, M., M. Gagné, L., Lalonde, M.-E., Germain, M.-A., Motorina, A., Guiot, M.-C., Secco, B., Vincent, E. E., Tumber, A., Hulea, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12700 · Cited by 180 · see citing works
Li, Y., Zhang, P., Wang, C., Han, C., Meng, J., Liu, X., Xu, S., Li, N., Wang, Q., Shi, X., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.454538 · Cited by 177 · see citing works
Oncometabolites: Unconventional triggers of oncogenic signalling cascades
Sciacovelli, M., & Frezza, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.025 · Cited by 177 · see citing works
Self-citationMetabolic changes in cancer: beyond the Warburg effect
Wu, W., & Zhao, S. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms104 · Cited by 173 · see citing works
Mutations in the d-2-Hydroxyglutarate Dehydrogenase Gene Cause d-2-Hydroxyglutaric Aciduria
Struys, E. A., Salomons, G. S., Achouri, Y., Van Schaftingen, E., Grosso, S., Craigen, W. J., Verhoeven, N. M., & Jakobs, C. (2005) · The American Journal of Human Genetics · doi:10.1086/427890 · Cited by 172 · see citing works
Kim, S., Hwang, J., Xuan, J., Jung, Y. H., Cha, H.-S., & Kim, K. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097501 · Cited by 169 · see citing works
Cloning and analysis of gene regulation of a novel LPS-inducible cDNA
Lee, C. L., Jenkins, N., Gilbert, D., Copeland, N., & O'Brien, W. (1995) · Immunogenetics · doi:10.1007/bf00172150 · Cited by 165 · see citing works
Circulating Succinate is Elevated in Rodent Models of Hypertension and Metabolic Disease
Sadagopan, N., Li, W., Roberds, S. L., Major, T. C., Preston, G. M., Yu, Y., & Tones, M. A. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.05.010 · Cited by 164 · see citing works
The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis
Joshi, S., Tolkunov, D., Aviv, H., Hakimi, A. A., Yao, M., Hsieh, J. J.-D., Ganesan, S., Chan, C. S., & White, E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.059 · Cited by 161 · see citing works
YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer
Mi, W., Guan, H., Lyu, J., Zhao, D., Xi, Y., Jiang, S., Andrews, F. H., Wang, X., Gagea, M., Wen, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01173-4 · Cited by 159 · see citing works
Inhibition of Mitochondrial Aconitase by Succination in Fumarate Hydratase Deficiency
Ternette, N., Yang, M., Laroyia, M., Kitagawa, M., O’Flaherty, L., Wolhulter, K., Igarashi, K., Saito, K., Kato, K., Fischer, R., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.02.013 · Cited by 158 · see citing works
Valls-Lacalle, L., Barba, I., Miró‐Casas, E., Alburquerque-Béjar, J. J., Ruiz‐Meana, M., Fuertes‐Agudo, M., Rodríguez‐Sinovas, A., & David Garcia-dorado, A. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv279 · Cited by 149 · see citing works
Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling
Nadtochiy, S. M., Schafer, X., Fu, D., Nehrke, K., Munger, J., & Brookes, P. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738799 · Cited by 143 · see citing works
Nota, B., Struys, E. A., Pop, A., Jansen, E. E., Fernandez Ojeda, M. R., Kanhai, W. A., Kranendijk, M., van Dooren, S. J. M., Bevova, M. R., Sistermans, E. A., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.03.009 · Cited by 138 · see citing works
Gibson, G. E., Xu, H., Chen, H., Chen, W., Denton, T. T., & Zhang, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13096 · Cited by 137 · see citing works
Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human
Rustin, P., Bourgeron, T., Parfait, B., Chretien, D., Munnich, A., & Rötig, A. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00035-5 · Cited by 137 · see citing works
Németh, B., Doczi, J., Csete, D., Kacso, G., Ravasz, D., Adams, D., Kiss, G., Nagy, A. M., Horvath, G., Tretter, L., et al. (2016) · The FASEB Journal · doi:10.1096/fj.15-279398 · Cited by 136 · see citing works
Mitochondrial metabolites: undercover signalling molecules
Frezza, C. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0100 · Cited by 136 · see citing works
Self-citationD‐2‐hydroxyglutaric aciduria: Case report and biochemical studies
Chalmers, R. A., Lawson, A. M., Watts, R. W. E., Tavill, A. S., Kamerling, J. P., Hey, E., & Ogilvie, D. (1980) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02312516 · Cited by 135 · see citing works
Topçu, M., Jobard, F., Halliez, S., Coskun, T., Yalçinkayal, C., Gerceker, F. O., Wanders, R. J. A., Prud'homme, J.-F., Lathrop, M., Özguc, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh300 · Cited by 133 · see citing works
Uddin, M. J., Joe, Y., Kim, S., Jeong, S. O., Ryter, S. W., Pae, H., & Chung, H. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.02 · Cited by 130 · see citing works
Food Fight: Role of Itaconate and Other Metabolites in Antimicrobial Defense
Luan, H. H., & Medzhitov, R. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.013 · Cited by 130 · see citing works
Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells
Rasola, A., Neckers, L., & Picard, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.005 · Cited by 129 · see citing works
Xie, L., Liu, W., Li, Q., Chen, S., Xu, M., Huang, Q., Zeng, J., Zhou, M., & Xie, J. (2015) · Journal of Proteome Research · doi:10.1021/pr500859a · Cited by 128 · see citing works
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Brück, J., Dringen, R., Amasuno, A., Pau‐Charles, I., & Ghoreschi, K. (2018) · Experimental Dermatology · doi:10.1111/exd.13548 · Cited by 128 · see citing works
Zhang, W., Petrovic, J.-M., Callaghan, D., Jones, A., Cui, H., Howlett, C., & Stanimirovic, D. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.01.014 · Cited by 125 · see citing works
Dimethyl Itaconate Is Not Metabolized into Itaconate Intracellularly
ElAzzouny, M., Tom, C. T. M. B., Evans, C. R., Olson, L. L., Tanga, M. J., Gallagher, K. A., Martin, B. R., & Burant, C. F. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.c117.775270 · Cited by 125 · see citing works
He, D., Wang, Q., Li, M., Damaris, R. N., Yi, X., Cheng, Z., & Yang, P. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00805 · Cited by 124 · see citing works
Mu, X., Zhao, T., Xu, C., Shi, W., Geng, B., Shen, J., Zhang, C., Pan, J., Yang, J., Hu, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14485 · Cited by 124 · see citing works
<i>IDH1</i> Mutation Induces Reprogramming of Pyruvate Metabolism
Izquierdo-Garcia, J. L., Viswanath, P., Eriksson, P., Cai, L., Radoul, M., Chaumeil, M. M., Blough, M., Luchman, H. A., Weiss, S., Cairncross, J. G., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0840 · Cited by 123 · see citing works
Advances in the development of histone lysine demethylase inhibitors
Maes, T., Carceller, E., Salas‐Salvadó, J., Ortega, A., & Buesa, C. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.05.009 · Cited by 121 · see citing works
Blatnik, M., Thorpe, S. R., & Baynes, J. W. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.047 · Cited by 109 · see citing works
Hagen, T. (2012) · Biochemistry Research International · doi:10.1155/2012/436981 · Cited by 100 · see citing works
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1978-z · Cited by 99 · see citing works
Mechanism of action of isocitrate lyase from Pseudomonas indigofera
McFadden, B. A., Williams, J. O., & Roche, T. E. (1971) · Biochemistry · doi:10.1021/bi00784a017 · Cited by 99 · see citing works
Non-targeted metabolite profiling in activated macrophage secretion
Sugimoto, M., Sakagami, H., Yokote, Y., Onuma, H., Kaneko, M., Mori, M., Sakaguchi, Y., Soga, T., & Tomita, M. (2012) · Metabolomics · doi:10.1007/s11306-011-0353-9 · Cited by 95 · see citing works
Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects
Tyrakis, P. A., Yurkovich, M. E., Sciacovelli, M., Papachristou, E. K., Bridges, H. R., Gaude, E., Schreiner, A., D’Santos, C. S., Hirst, J., Hernandez-Fernaud, J. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.092 · Cited by 95 · see citing works
Self-citationKohlhauer, M., Dawkins, S., Costa, A. S. H., Lee, R., Young, T., Pell, V. R., Choudhury, R. P., Banning, A. P., Kharbanda, R. K., Study, O. A. M. I. (., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007546 · Cited by 91 · see citing works
Self-citationValls-Lacalle, L., Barba, I., Miró-Casas, E., Ruiz-Meana, M., Rodríguez-Sinovas, A., & García-Dorado, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-20866-4 · Cited by 88 · see citing works
Hamel, D., Sanchez, M., Duhamel, F., Roy, O., Honoré, J.-C., Noueihed, B., Zhou, T., Nadeau-Vallée, M., Hou, X., Lavoie, J.-C., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302131 · Cited by 86 · see citing works
Bénit, P., Letouzé, É., Rak, M., Aubry, L., Burnichon, N., Favier, J., Gimenez‐Roqueplo, A., & Rustin, P. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2014.03.013 · Cited by 86 · see citing works
Tannahill, G. M., & O'Neill, L. A. J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.008 · Cited by 84 · see citing works
Self-citationNon-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases
Tarhonskaya, H., Rydzik, A. M., Leung, I. K. H., Loik, N. D., Chan, M. C., Kawamura, A., McCullagh, J. S. O., Claridge, T. D. W., Flashman, E., & Schofield, C. J. (2014) · Nature Communications · doi:10.1038/ncomms4423 · Cited by 80 · see citing works
Discovery of a potent and selective small molecule hGPR91 antagonist
Bhuniya, D., Umrani, D., Dave, B., Salunke, D., Kukreja, G., Gundu, J., Naykodi, M., Shaikh, N. S., Shitole, P., Kurhade, S., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.091 · Cited by 80 · see citing works
2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter
Yang, Z., Jiang, B., Wang, Y., Ni, H., Zhang, J., Xia, J., Shi, M., Hung, L.-M., Ruan, J., Mak, T. W., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.012 · Cited by 78 · see citing works
Role of hypoxia inducible factor-1α for interferon synthesis in mouse dendritic cells
Wobben, R., Hüsecken, Y., Lodewick, C., Sutter, K., Fandrey, J., & Winning, S. (2013) · Biological Chemistry · doi:10.1515/hsz-2012-0320 · Cited by 77 · see citing works
Cheon, Y.-P., Xu, X., Bagchi, M. K., & Bagchi, I. C. (2003) · Endocrinology · doi:10.1210/en.2003-0585 · Cited by 76 · see citing works
Chen, J.-Y., Lai, Y.-S., Tsai, H., Kuo, C.-C., Yen, B. L., Yeh, S., Sun, H. S., & Hung, W.-C. (2016) · Scientific Reports · doi:10.1038/srep32428 · Cited by 73 · see citing works
Sherwin, J. R. A., Freeman, T. C., Stephens, R. J., Kimber, S., Smith, A. G., Chambers, I., Smith, S. K., & Sharkey, A. M. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0110 · Cited by 68 · see citing works
Identification and pharmacological characterization of succinate receptor agonists
Geubelle, P., Gilissen, J., Dilly, S., Poma, L., Dupuis, N., Laschet, C., Abboud, D., Inoue, A., Jouret, F., Pirotte, B., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13738 · Cited by 63 · see citing works
El‐Khoury, R., Kemppainen, K. K., Dufour, E., Szibor, M., Jacobs, H. T., & Rustin, P. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12570 · Cited by 56 · see citing works
Kerins, M. J., Vashisht, A. A., Liang, B. X.-T., Duckworth, S. J., Praslicka, B. J., Wohlschlegel, J. A., & Ooi, A. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00079-17 · Cited by 56 · see citing works
Assessing histone demethylase inhibitors in cells: lessons learned
Hatch, S. B., Yapp, C., Montenegro, R. C., Savitsky, P. A., Gamble, V., Tumber, A., Ruda, G. F., Bavetsias, V., Fedorov, O., Atrash, B., et al. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0116-6 · Cited by 55 · see citing works
Osinalde, N., Mitxelena, J., Sánchez-Quiles, V., Akimov, V., Aloria, K., Arizmendi, J. M., Zubiaga, A. M., Blagoev, B., & Kratchmarova, I. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.057158 · Cited by 48 · see citing works
Immune responsive gene 1, a novel oncogene, increases the growth and tumorigenicity of glioma
PAN, J., ZHAO, X., LIN, C., XU, H., YIN, Z., LIU, T., & ZHANG, S. (2014) · Oncology Reports · doi:10.3892/or.2014.3474 · Cited by 45 · see citing works
Fumaric aciduria: an overview and the first Brazilian case report
Allegri, G., Fernandes, M. J., Scalco, F. B., et al. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9134-2 · Cited by 45 · see citing works
Feng, S., Jiao, K., Guo, H., Jiang, M., Hao, J., Wang, H., & Shen, C. (2017) · BMC Genomics · doi:10.1186/s12864-017-3978-x · Cited by 43 · see citing works
Johnson, T. I., Costa, A. S. H., Ferguson, A. N., & Frezza, C. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0912-3 · Cited by 40 · see citing works
Self-citationInflammation, HIF-1, and the Epigenetics That Follows
Brigati, C., Banelli, B., Vinci, A. D., Casciano, I., Allemanni, G., Forlani, A., Borzì, L., & Romani, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/263914 · Cited by 34 · see citing works
Effect of TET inhibitor on bovine parthenogenetic embryo development
Zhang, J., Zhang, S., Wang, Y., Cheng, H., Hao, L., Zhai, Y., Zhang, Z., An, X., Ma, X., Zhang, X., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189542 · Cited by 34 · see citing works
Jiang, B., Zhang, J., Xia, J., Zhao, W., Wu, Y., Shi, M., Luo, L., Zhou, H., Chen, A., Ma, H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.053 · Cited by 33 · see citing works
Regulation of the 2-oxoglutarate-dependent dioxygenases and implications for cancer
Vissers, M. C. M., Kuiper, C., & Dachs, G. U. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140118 · Cited by 32 · see citing works
Dimethyl fumarate: targeting glycolysis to treat MS
Angiari, S., & O’Neill, L. A. (2018) · Cell Research · doi:10.1038/s41422-018-0045-3 · Cited by 27 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Cellular Adaptation to Hypoxia through Hypoxia Inducible Factors and beyond
Lee, P., Chandel, N. S., & Simon, M. C. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0227-y · Cited by 1,272 · see citing works
Cellular senescence: all roads lead to mitochondria
Martini, H., & Passos, J. F. (2023) · The FEBS Journal · doi:10.1111/febs.16361 · Cited by 334 · see citing works
Lonnemann, N., Hosseini, S., Marchetti, C., Skouras, D. B., Stefanoni, D., D’Alessandro, A., Dinarello, C. A., & Korte, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009680117 · Cited by 298 · see citing works
Compartmentalised acyl-CoA metabolism and roles in chromatin regulation
Trefely, S., Lovell, C. D., Snyder, N. W., & Wellen, K. E. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.005 · Cited by 272 · see citing works
Ins and outs of the TCA cycle: the central role of anaplerosis
Inigo, M., Deja, S., & Burgess, S. C. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120420-025558 · Cited by 189 · see citing works
Inter‐organ communication: a gatekeeper for metabolic health
Castillo‐Armengol, J., Fajas, L., & Lopez‐Mejia, I. C. (2019) · The EMBO Reports · doi:10.15252/embr.201947903 · Cited by 178 · see citing works
2-Hydroxyglutarate in Cancer Cells
Ježek, P. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7902 · Cited by 130 · see citing works
Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses
Lesbats, J., Brillac, A., Reisz, J. A., Mukherjee, P., Lhuissier, C., Fernández-Monreal, M., Dupuy, J.-W., Sequeira, A., Tioli, G., De La Calle Arregui, C., et al. (2025) · Nature · doi:10.1038/s41586-025-08629-4 · Cited by 74 · see citing works
- Authors
- Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L.
- Affiliations
- Trinity College Dublin (IE)
- University of Cambridge (GB)
- Harvard University (US)
- ORCID
- Venue
- Nature Metabolism
- Published
- 2018-12-30
- Volume
- 1
- Issue
- 1
- Pages
- 16-33
- ISSN
- 2522-5812 (ISSN-L)
- PMC
- PMC6485344
- OpenAlex
- W2907926991
- Semantic Scholar
- b15b8b89360b980cc180d451684d173275b9488c
- Cited by
- 398
- References
- 205
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 70 · 2023: 41 · 2022: 66 · 2021: 66 · 2020: 61 · 2019: 20
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (110158/Z/15/Z, 205455, 110159/Z/ 15/Z, 109443/Z/15/Z)
- Medical Research Council (MC_UU_00015/3, MC_UU_12022/6)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Krebs cycle metabolites, metabolic reprogramming, succinic acid, fumarate, itaconate, 2-hydroxyglutarate, acetyl-CoA, immune cell function, cancer, carcinogenesis, tumor immunology, therapeutic target
- MeSH terms
- Citric Acid Cycle, Humans, Immunity, Innate, Macrophages, Neoplasms, Succinate Dehydrogenase, Succinates, Signal Transduction, Succinic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review